Skip to main content
Frontiers in Cellular Neuroscience logoLink to Frontiers in Cellular Neuroscience
. 2017 Apr 5;11:90. doi: 10.3389/fncel.2017.00090

New Implications for the Melanocortin System in Alcohol Drinking Behavior in Adolescents: The Glial Dysfunction Hypothesis

Juan A Orellana 1,2,*, Waldo Cerpa 1,3, Maria F Carvajal 1,4, José M Lerma-Cabrera 1,4, Eduardo Karahanian 1,4, Cesar Osorio-Fuentealba 1,5, Rodrigo A Quintanilla 1,6,*
PMCID: PMC5380733  PMID: 28424592

Abstract

Alcohol dependence causes physical, social, and moral harms and currently represents an important public health concern. According to the World Health Organization (WHO), alcoholism is the third leading cause of death worldwide, after tobacco consumption and hypertension. Recent epidemiologic studies have shown a growing trend in alcohol abuse among adolescents, characterized by the consumption of large doses of alcohol over a short time period. Since brain development is an ongoing process during adolescence, short- and long-term brain damage associated with drinking behavior could lead to serious consequences for health and wellbeing. Accumulating evidence indicates that alcohol impairs the function of different components of the melanocortin system, a major player involved in the consolidation of addictive behaviors during adolescence and adulthood. Here, we hypothesize the possible implications of melanocortins and glial cells in the onset and progression of alcohol addiction. In particular, we propose that alcohol-induced decrease in α-MSH levels may trigger a cascade of glial inflammatory pathways that culminate in altered gliotransmission in the ventral tegmental area and nucleus accumbens (NAc). The latter might potentiate dopaminergic drive in the NAc, contributing to increase the vulnerability to alcohol dependence and addiction in the adolescence and adulthood.

Keywords: alcohol drinking, melanocortins, neuroinflammation, metabolism and bioenergetics, synaptic dysfunction

Introduction

Alcohol is the most commonly used and abused drug worldwide (Koob and Le Moal, 2005). According to the Global Information System on Alcohol and Health (World Health Organization, 2014), the annual consumption during 2010 was equal to 6.2 L of pure alcohol per person aged 15 years or older, which implies consumption of 13.5 g of pure alcohol per day. Alcoholism is a complex and multifactorial disorder characterized by a lack of control over excessive alcohol consumption, in spite of its significant negative consequences (Edenberg and Foroud, 2013). Individuals suffering of this disorder exhibit compulsive alcohol use and a loss of behavioral control, as well as alcohol tolerance and withdrawal symptoms, which may include anxiety, depressive episodes, social avoidance, insomnia, nausea and seizures, generating substantial health, societal and economic consequences (Spanagel, 2009). In fact, alcohol abuse causes approximately 3.3 million deaths every year (or 5.9% of all deaths), and 5.1% of the global burden of disease is attributable to this dependence syndrome. Given this, in 2014 the World Health Assembly approved a resolution to urge countries to strengthen their national responses to public health problems caused by the harmful use of alcohol (World Health Organization, 2014).

As occur with other drugs, addiction to alcohol is a chronically relapsing disorder characterized by (i) compulsion to seek and drink alcohol, (ii) loss of control in limiting consume, and (iii) appearance of a negative emotional state (e.g., stress, dysphoria, anxiety) reflecting a motivational withdrawal syndrome when access to alcohol is prevented (defined as dependence) (Koob, 2013; Ron and Barak, 2016). Most of people begin to consume alcohol as part of experimentation and social drinking, which is accompanied of anxiolytic feelings and rewarding, as well as socially facilitating effects (Everitt and Robbins, 2005). When a person repeatedly consumes alcohol, develops tolerance to it and drinking may become more automatic and less voluntary (Everitt and Robbins, 2005). From a neurobiological perspective, in this stage of the addiction cycle, alcohol consumption is a goal-directed behavior, initiated and executed by brain areas within the executive control network, with its rewarding effects processed by appetitive drive regions (Kyzar and Pandey, 2015). These crucial anatomical circuits comprise the mesocorticolimbic dopamine system that originates in the ventral tegmental area (VTA) and projects to the nucleus accumbens (NAc), opioid peptides in the ventral striatum, extended amygdala, and VTA, and glutamate in the dorsolateral prefrontal cortex and anterior cingulate cortex (Koob, 2013). The behavioral transformation between pursuing impulsively alcohol for its rewarding effects (positive reinforcement) and seeking compulsively alcohol in order to remove the negative emotional state associated with withdrawal (negative reinforcement) are clinical features of alcohol addiction (Koob, 2013).

Alcohol abuse not only occurs in the adult population, but is also a well-known health concern during adolescence (Brown and Tapert, 2004). Indeed, information from the WHO’s Global Burden of Disease study reveals that 7.4% of all disabilities and premature deaths in people aged 10–24 years are attributable to alcohol, followed by unsafe sex (4%) or illicit drug use (2%) (Gore et al., 2011). This evidence supports the idea that the onset of drinking at an early age increases the risk of developing an alcohol use disorder in adulthood (DeWit et al., 2000). Currently, several governmental and health institutions worldwide are seeking preventive strategies focused on understanding the etiology of alcohol drinking behavior in young people. Here, we examine the molecular mechanisms that prompt alcohol use and abuse in adolescents by focusing in the possible role of glial cell signaling and melanocortin (MC) system. In particular, we address the signaling pathways that contribute to the switch from moderate to uncontrolled excessive alcohol intake and dependence. As alcoholism is thought to be a maladaptive form of learning and memory that impact whole body homeostasis, we also incorporate possible pathway molecules that have been linked to synaptic plasticity, learning and memory, as well as whole body metabolism.

Heavy Episodic Drinking in Adolescents and Brain Circuits Involved

In the last years, it has been observed that a growing number of adolescents drink alcoholic beverages with the intention of becoming intoxicated (Center for Disease Control, 2013). This binge drinking practice is characterized by the consumption of large amounts of alcohol over a short time period (minutes to hours), especially during leisure time and at weekends, with periods of abstinence between drinking episodes. In spite of the fact that young people drink less often than adults, most adolescents drink more than twice as much alcohol per drinking episode on average when compared to adults (Center for Disease Control, 2013).

In 2004, the National Institute for Alcohol Abuse and Alcoholism (NIAAA) defined binge drinking as a pattern of alcohol consumption that results in a blood alcohol concentration (BAC) of 0.08 g/dL or greater (NIAAA Newstetter, 2004). Usually people adopting this behavior drink five or more drinks in less than two hours. This heavy drinking pattern produces several short- and long-lasting negative effects in adolescents. According to the Global Burden of Disease Study of 2013, alcohol abuse was the highest risk factor for disability-adjusted life-years (7 % overall, 10.5% for males, and 2.7% for females) for young people aged between 20 and 24 years (Mokdad et al., 2016). In addition, heavy alcohol consumption during adolescence is associated with significant mental health impairment and adverse social effects (McBride and Cheng, 2011), as well as the increased probability of using and abusing other drugs, such as tobacco, marijuana or other illicit drugs (Kirby and Barry, 2012). The relationship between early alcohol consumption in young people and the increased risk of developing alcoholism during adulthood has been well documented. In fact, several studies have reported that alcohol consumption prior to 14 years old produces a 4-fold increase in the risk of becoming alcohol dependent in adulthood (DeWit et al., 2000; Dawson et al., 2008).

Clinical and animal studies have revealed that adolescents are more susceptible to alcohol influence than adults (Donovan, 2004; Spear and Swartzwelder, 2014). Adolescence is the period of life particularly crucial for development of brain circuits responsible for emotion and cognition, involving changes in cortical volume, axonal growth, gene expression, and refinement of cortical connections by a process known as “synaptic pruning” (Tau and Peterson, 2010). The prefrontal cortex and the limbic system are two important networks that exhibit ongoing structural and functional maturation in adolescents and young adults (Arain et al., 2013; Caballero et al., 2016). While the prefrontal cortex is involved in higher cognitive processing related to executive functioning (e.g., planning, goal setting, inhibitory control), decision making, and cognitive-affective behaviors (Gourley and Taylor, 2016), the limbic system govern social and emotional processing and is critical for immediate reward processing (Rolls, 2015). The adolescent brain is particularly susceptible to the detrimental effects of alcohol abuse given the so called “windows of vulnerability” created by the earlier developing limbic system and brain affective regions relative to the later maturation of the prefrontal cortex (Crews et al., 2007). This “maturational lag” produces that when making decisions, adolescents show increased involvement of appetitive/impulsive motivational systems (e.g., drink alcohol for immediate reward), but blunted recruitment of top–down executive controls of the prefrontal cortex (Steinberg, 2007; Crews et al., 2007). The asymmetry between brain areas involved in the impulsive emotionality and those implicated in reflective and executive function may make adolescents more vulnerable to engaging in addictive behaviors, including alcoholism. Interestingly, some studies suggest that most drugs related to addictive behaviors may strengthen this imbalance (Bechara, 2005). This highly sensitivity to positive rewarding effects of alcohol along with the fact that young people are less sensitive to negative aspects of alcohol abuse (e.g., sedative effects); it may explain the excessive alcohol intake during adolescence (Donovan, 2004; Spear and Swartzwelder, 2014). In this context, heavy alcohol drinking during adolescence could exerts long-lasting impacts on adult brain networks, causing different changes including impairment of intellectual function, rational decision making, and emotional maturation.

What brain circuits linked to positive rewarding and appetitive/impulsive function are hyper activated at the initial stages of alcohol intoxication in adolescents? Similar to adults, adolescents that engaged in binge drinking practices exhibit increased dopaminergic function at the VTA and NAc, as well as glutamatergic drive in the prefrontal cortex, which are likely brain regions involved in the reinforcing effects of acute alcohol abuse (Pascual et al., 2009; Maldonado-Devincci et al., 2010; Allen et al., 2011). Another important brain region that undergoes long-lasting neuroadaptive changes during alcohol abuse in adults and adolescents is the hypothalamus (Barson and Leibowitz, 2016). Indeed, different orexigenic neuropeptides acting at the hypothalamus (e.g., galanin, encephalin, orexin) stimulate alcohol consumption by enhancing positive reward and most of them are upregulated by alcohol, which potentiate even further consumption (Rada et al., 2004; Schneider et al., 2007; Barson et al., 2010). Conversely, well-known neuropeptides that have anorexigenic properties, including the endogenous opioid dynorphin, corticotropin-releasing factor, and MCs, inhibit alcohol drinking along with the positive reward achieved by its consumption (Navarro et al., 2003; Thorsell et al., 2005; Barson et al., 2010). The abnormal expression of these neuropeptides and their receptors, besides their impact at the limbic system have emerged as pivotal factors for developing alcohol-related drinking behaviors and thereby, this knowledge has been used also to explain alcohol binge drinking patterns in adolescents (Crews et al., 2000; Slawecki et al., 2004).

Accumulating anatomical, genetic, and pharmacological evidence has shown that the MC pathway in the hypothalamus and other brain areas is critical for developing dependency and addictive behaviors related to alcohol consumption (Olney et al., 2014). However, the molecular and cellular mechanisms behind these changes remain to be fully understood and this is particularly true for the initial stages of alcohol dependency in adolescents.

Crosstalk Between Alcohol Consumption and Melanocortin System

Within the arcuate nucleus of the hypothalamus (Arc) and the nucleus of the solitary tract (NST), cleavage of the polypeptide precursor pro-opiomelanocortin (POMC) gives born to different MC peptides (Cone, 2005; Ellacott and Cone, 2006) (Figure 1). Among these are α-, β-, and γ-melanocyte stimulating hormones (MSH), as well as adrenocorticotrophic hormone (ACTH) (Hadley and Haskell-Luevano, 1999). In rodents, MC peptides act through at least five receptor subtypes, namely MC1-5R, which are coupled to heterotrimeric G-proteins that stimulate adenylyl cyclase activity (Hadley and Haskell-Luevano, 1999). MC3R and MC4R are the most predominant MCR subtypes expressed in the brain (Mountjoy, 2010b). Immunohistochemical and in situ hybridization studies have detected MC4R localization in various brain regions, including the hippocampus, paraventricular nucleus of the hypothalamus (PVN), Arc, ventromedial hypothalamus (VMH), amygdala, VTA, and NAc (Kishi et al., 2003; Liu et al., 2003). Similar evidence has shown the specific expression of MC3Rs in the hypothalamus and the limbic system (Roselli-Rehfuss et al., 1993). Interestingly, both receptors have an endogenous agonist (α-MSH), and an physiological antagonist (agouti-related protein; AgRP) (Haskell-Luevano and Monck, 2001; Nijenhuis et al., 2001; Chai et al., 2003). These transmitters display opposing actions on MC3Rs and MC4Rs, impacting neuronal circuits and further hypothalamic-dependent physiological functions (Figure 1).

FIGURE 1.

FIGURE 1

The hypothalamic melanocortin system. In the arcuate nucleus of the hypothalamus (Arc), neuropeptide Y/agouti-related protein/γ-amino butyric acid (AgRP/NPY/GABA) neurons (blue) embrace the first-order sensory networks of the melanocortin (MC) system. These neurons project to second-order target areas to regulate multiple physiological functions, including the neurobiological responses to alcohol abuse. NYP (blue) acts on Y1, as well as on Y2 and Y5 receptors (not depicted), whereas via activation of its metabotropic receptors, GABA may establish an inhibitory tone (1). AgRP is a potent endogenous antagonist of MC3Rs and MC4Rs, and therefore, antagonizes actions of α-melanocyte-stimulating hormone (α-MSH) (2). At the other end, pro-opiomelanocortin/cocaine- and amphetamine-regulated transcript (POMC/CART) neurons (red) constitute the other first-order sensory network in the MC system at the Arc. They synthesize α-MSH and release it to activate MC receptors in different second-order regions of the brain (3). In addition, GABA released from NPY/AgRP/GABA neurons suppresses the action of α-MSH by inhibiting POMC/CART neurons at the Arc (4).

Multiple studies have revealed the involvement of MC system in the neurobiological response to alcohol consumption. In the first place, α-MSH and other MCs are expressed in different brain areas involved in the neurobiological response to ethanol, including the striatum, NAc, VTA, amygdala, hippocampus, and hypothalamus (Dube et al., 1978; Jacobowitz and O’Donohue, 1978; Bloch et al., 1979; O’Donohue et al., 1979; O’Donohue and Jacobowitz, 1980; Yamazoe et al., 1984). Second, intracerebroventricular infusion of a non-selective MCR agonist, melatonin-II, reduces voluntary ethanol drinking in adult alko alcohol (AA) rats (Ploj et al., 2002) and C57BL/6J mice (Navarro et al., 2003), while the administration of AgRP increases alcohol consumption (Navarro et al., 2003). Importantly, MCR agonists fail in mitigate alcohol intake on mutant mice lacking MC4Rs (Navarro et al., 2011), unveiling the fundamental role of this receptor in dependency and behavioral response to alcohol (Navarro et al., 2011). In agreement with these data, infusion of a selective MC4R agonist (cyclo (NH-CH2-CH2-CO-His-D-Phe-Arg-Trp-Glu)-NH2) at the NAc and VTA, but not into the lateral hypothalamus (LH), diminish voluntary alcohol consumption in rats (Lerma-Cabrera et al., 2012). Follow-up work has demonstrated that MC signaling within the NAc contributes to alcohol consumption by modulating the non-homeostatic aspects (palatability) of intake (Lerma-Cabrera et al., 2013b), which bring to light the key role of MCs in limbic regions implicated in the hedonic response to alcohol.

The interaction between MCs and alcohol is not only limited to the neuromodulatory effect of these transmitters on alcohol consumption, but also implies the well-known regulation of alcohol on MC system. Numerous animal research has demonstrated that ethanol, the predominant alcohol in alcoholic beverages, disturbs the function of MC system depending on how this drug is administered (for review see Olney et al., 2014). For example, acute exposure to ethanol results in a drastic reduction of α-MSH-immunoreactivity in the PVN, Arc, and dorsomedial hypothalamic-dorsal (DMNd) and -ventral (DMNv) nuclei, as well as the central nucleus of amygdala (CeA) (Kokare et al., 2008). Similar findings have been found by others groups in the Arc, LH, CeA, and the paraventricular nucleus of the thalamus (PVT) in rats subjected to acute and chronic treatment with ethanol (Navarro et al., 2008). In addition, chronic exposure to an ethanol-containing diet significantly decreases levels of POMC in the Arc in conjunction with the expression of pro- prohormone convertases 1 (PC1) and 2 (PC2), both responsible for POMC processing (Navarro et al., 2013). In contrast, other works indicate that chronic ethanol treatment significantly raises the α-MSH-immunoreactivity in the PVN, Arc, DMNd, DMNv, and CeA, response that is potentiated following 24 h ethanol withdrawal (Kokare et al., 2008). The reasons for this discrepancy may rely in differences in the dose and duration of ethanol treatment. Another relevant issue that may explain the diverse outcomes regarding the regulation of MC system under different ethanol consumption paradigms is the innate differences. As such, C57BL/6J mice, which display high rates of voluntary ethanol intake, have elevated basal α-MSH immunoreactivity in hypothalamic areas and lower α-MSH expression in the medial amygdala relative to 129/SvJ mice, a strain which exhibit low rates of spontaneous ethanol consumption (Cubero et al., 2010). In the same way, AA rats, which are selectively bred to prefer ethanol, exhibit abnormal expression patterns of MC3Rs in the PVN, Arc, and VMH compared to alko-non-alcohol (ANA) rats (Lindblom et al., 2002). Together these findings suggest that the different patterns of drinking observed amongst these animals may be attributable to innate differences in the function of the MC system.

Nowadays, although plenty of evidence support the involvement of MC system in adult alcoholism, the contribution of this pathway in binge drinking during adolescence is just beginning to be explored (Lerma-Cabrera et al., 2013a). In the following sections, we describe and discuss some of the possible mechanisms underlying this issue.

Astrocytes and Microglia: Primary Targets of Alcohol Abuse

Astroglial Dysfunction and Alcohol Abuse

Astrocytes constitute the major glial cell type in the CNS and encompass a far-reaching syncytial network that anatomically and functionally connect neuronal synapses with brain blood vessels (Volterra and Meldolesi, 2005; Barres, 2008; Perea et al., 2009). Astroglial processes, together with pre- and postsynaptic neuronal complexes, embrace the “tripartite synapse” (Schafer et al., 2013). Within this anatomical and functional arrangement, astrocytes sense neuronal activity and respond locally through the release of bioactive molecules termed “gliotransmitters” (e.g., glutamate, ATP, and D-serine) (Perea et al., 2009). Besides to surrounding the synaptic cleft, astrocytes project the well-known specialized terminal processes called “endfeet”, toward multiple vascular elements, including capillaries, intracerebral arterioles and venules (Simard et al., 2003). The above provides to astrocytes with an unparalleled architectural position to favor the local and long distance release of gliotransmitters and vasoactive factors that control different neuronal circuits. Along with their trophic and synaptic role in the brain parenchyma, astrocytes are major protagonists in supplying energy to neurons (e.g., lactate), maintaining the homeostatic balance of extracellular pH, neurotransmitters and ions, as well as controlling the reactive oxygen species (ROS) response and intercellular communication and propagation of Ca2+ signaling.

Does alcohol consumption affect astrocyte function? A vast number of studies have shown that astrocytes subjected to in vitro and in vivo alcohol administration become activated and undergo long-lasting molecular and morphological changes, referred to as reactive astrogliosis (Blanco and Guerri, 2007; Adermark and Bowers, 2016; Saito et al., 2016). This phenomenon constitutes a graded, multistage and evolutionarily conserved astroglial reaction that counteract acute damage, restoring the homeostasis and limiting the brain parenchyma injury (Pekny and Nilsson, 2005). Along with hypertrophy of astrocytes processes and enlargement of the intermediate filament network via upregulation of glial fibrillary acidic protein (GFAP), this reaction also involves disturbances on astroglial functions such as altered gliotransmission and Ca2+ signaling, elevated production of cytokines and nitric oxide (NO) (Pekny and Nilsson, 2005). Despite that reactive astrogliosis is an adaptive mechanism of protection, when it persists, can turn into a detrimental response, leading to neuronal damage and recruitment of the innate immune response.

In terms of astrocyte number and GFAP expression, ethanol seems to induce different outcomes depending on developmental period, addiction stage, brain region and method of ethanol administration (e.g., amount and periodicity of exposure) (Bull et al., 2015). For example, adult rats exposed to repeated gavage of ethanol or ethanol-containing diet exhibit an increased number of GFAP positive astrocytes in the cerebral cortex (Dalcik et al., 2009; Udomuksorn et al., 2011) and similar findings have been observed at the prelimbic and anterior cingulate cortex (Bull et al., 2014) or during ethanol abstinence at the prelimbic cortex (Miguel-Hidalgo et al., 2006) and Nac (Bull et al., 2014). In contrast, prelimbic and orbitofrontal prefrontal cortex of rats that had continuous access to ethanol show a reduction in GFAP positive astrocytes after 3-week abstinence, whereas astrocyte density decreases at the anterior cingulate and orbitofrontal cortex during abstinence in a model of operant ethanol self-administration (Bull et al., 2015). In the same manner, a diminished astrocyte number is also found in the rat dorsolateral and orbitofrontal prefrontal cortex (Miguel-Hidalgo et al., 2002, 2006) and hippocampus of human alcoholics (Korbo, 1999). These changes also take place in adolescents and young adults. Indeed, ethanol exposure increases the expression of GFAP and the number of astrocytes in the hippocampus, corpus stratum and frontal cortex of adolescent rodents (Evrard et al., 2006; Kane et al., 2014), whereas a recent study has found that chronic ethanol administration during adolescence reduced GFAP positive astrocytes at the CA3 hippocampal area and hilus sub-regions (Oliveira et al., 2015). As mentioned before, these conflicting results may be linked to differences in time of ethanol exposure, amounts and methods of administration.

Treatments with alcohol cause profound alterations in cell-to-cell coupling and electrophysiological properties of astrocytes. In fact, ethanol inhibits gap junctional coupling among astrocytes, whereas also blunts their slope of conductance, increase their input resistance and decreased their capacitance without affecting the resting membrane potential (Adermark et al., 2004; Adermark and Lovinger, 2006). In addition, acute ethanol exposure induces astroglial swelling and intracellular free Ca2+ concentration ([Ca2+]i) transients (Allansson et al., 2001), whereas Gonzalez and colleagues linked this response with ROS production and further increased expression of GFAP (Gonzalez et al., 2007). Follow-up studies revealed that ethanol-induced [Ca2+]i oscillations triggers the release of glutamate in astrocytes (Salazar et al., 2008), but inverse effects have been seen when they are pre-incubated with ethanol and further kainate-dependent release of glutamate is analyzed (Santofimia-Castaño et al., 2011). At one end, this ethanol-mediated regulation of extracellular glutamate has been attributed to alterations in the expression and function of astroglial excitatory amino acid transporters GLAST and GLT-1 in brain regions linked to positive reward, including the Nac (Smith and Zsigo, 1996; Zink et al., 2004; Alhaddad et al., 2014; Smith et al., 2014; Das et al., 2015; Sari et al., 2016). These transporters remove glutamate from the extracellular environment and thereby, their function is crucial because excessive glutamate can lead to synaptic dysfunction and neuronal excitotoxicity (Ayers-Ringler et al., 2016). Ethanol blunts adenosine uptake via the inhibition of astrocytic nucleoside transporter 1 (ENT1), leading to increased levels of adenosine and activation of purinergic receptors, which result in the downregulation of GLT-1 and further enhanced levels of extracellular glutamate (Wu et al., 2010, 2011; Nam et al., 2012). At the other end, disturbances in extracellular levels of glutamate and other gliotransmitters have been associated to ethanol-mediated astroglial swelling. Indeed, acute treatment with ethanol triggers astrocyte swelling via Na+/K+/2Cl- cotransporter or the Na+/K+-ATPase, resulting in the release of glutamate, aspartate and taurine (Kimelberg et al., 1993; Allansson et al., 2001; Aschner et al., 2001a,b; Vargova and Sykova, 2014). Relevant to this point, extracellular levels of taurine are crucial for the ethanol-induced dopamine release in the Nac (Ericson et al., 2011). Furthermore, positive reward caused by impulsive alcohol consumption are associated with aquaporin-4 (AQP4) function (Lee et al., 2013) and its expression correlates with dopamine levels in the Nac (Kuppers et al., 2008), and suppression of cell swelling mitigates ethanol-induced dopamine release (Adermark et al., 2011). Altogether this evidence suggests that gliotransmitter release associated to transporters or astrocyte swelling is modulated by ethanol and could be determinant in regulating synaptic transmission in brain areas related to alcohol consumption.

A number of studies by Guerri’s group and others, have shown that in vitro or in vivo treatment with ethanol augments the function and/or expression of different inflammatory mediators in astrocytes, including cyclooxygenase 2 (COX2), cytochrome P4502E1, inducible NO synthase (iNOS), NO, IL-1β, and TNF-α (Montoliu et al., 1995; Blanco et al., 2004; Valles et al., 2004). Importantly, these effects base on the activation of different cellular pathways including the nuclear factor κB (NF-κB), IL-1β receptor type I (IL-1RI) and toll-like receptor type 4 (TLR4) (Blanco et al., 2004, 2005, 2008; Alfonso-Loeches et al., 2010). In particular, the ethanol-induced upregulation of iNOS, COX2, and IL-1β occurs via the stimulation of RhoE, as well as IRAK and MAP kinases, such as ERK1/2, p-38, and JNK, which trigger the downstream activation of oxidant-sensitive transcription factors NF-κB and AP-1 (Valles et al., 2004; Guasch et al., 2007). Alterations in the expression of pro-inflammatory immune genes occur in postmortem brain from alcoholics and animals exposed to alcohol, whereas molecules known to reduce inflammation have shown to ameliorate alcohol-mediated behaviors in animal models (Mayfield et al., 2013; Cui et al., 2014; Truitt et al., 2016; Nennig and Schank, 2017). Increased free radical production and low antioxidant levels are major features of alcohol-induced brain damage (Crews et al., 2000). At the CNS, mechanisms of antioxidant defense and metabolic homeostatic balance largely depend on glial cells, in particular astrocytes (Fernandez-Fernandez et al., 2012). Astrocyte-to-astrocyte signaling protects neurons against oxidative injury by suppressing the accumulation of free radicals and stabilizing Ca2+ homeostasis in neurons (Blanc et al., 1998). During early stages of alcohol consumption, astrocytes may help to compensate the alcohol abuse-induced disturbances in redox balance and antioxidant mechanisms. Accordingly, they prevent ethanol-induced neuronal death by maintaining glutathione (GSH) homeostasis (Watts et al., 2005; Narasimhan et al., 2012). Nonetheless, in situations of chronic and progressive alcohol abuse, ethanol may impair astroglial function, thus altering antioxidant and metabolic coupling between neurons and astrocytes. Supporting this line of thought, ethanol acutely reduces astrocytic gap junction coupling (Adermark et al., 2004; Adermark and Lovinger, 2006), and induces the production of free radicals, and further oxidative stress in astrocytes (Montoliu et al., 1995; Russo et al., 2001; Muscoli et al., 2002; Salazar et al., 2008). Under this view, anomalies in the inflammatory and antioxidant profile of astrocytes, along with the impairment of immune function of microglia (see next section), may be vital for the function of brain networks involved in alcohol reward and dependency.

Microglia-Mediated Inflammation and Redox Imbalance during Alcohol Abuse

Microglia comprises almost 5–15% of the entire number of brain cells and are the predominant pieces of the innate immune system at the CNS (Lawson et al., 1990). Originating from mielomonocytic precursor cells of the hemangioblastic mesoderm, microglia populates the brain parenchyma prior to the developmental closure of the blood–brain barrier (BBB) (Ginhoux et al., 2010). In the normal brain, most microglia displays a “resting” surveillance nature, which correlates with a dynamic environmental pursuing and unceasing seeking of exogenous or endogenous signals constituting a brain threat (Streit, 2001; Kettenmann et al., 2011). When homeostatic equilibrium is disturbed, the resting features of microglia turn into a reactive phenotype implicating a wide array of modifications in different microglial functions, including proliferation, morphology, motility, migration, proteostasis, phagocytosis and intercellular communication (Hanisch, 2002; Block et al., 2007). This complex number of changes is denominated as “microglial activation” and embrace large-scale and functional remodeling that depend on the nature, intensity and duration of the stimulus (Ransohoff and El Khoury, 2015). At this point, microglia becomes an unrestrained core of inflammatory mediators (e.g., cytokines and free radicals) that drive neuronal damage rather than exhibiting a repair-orientated profile (Block et al., 2007). Although an efficient immune response is necessary to resolve brain threats, under these circumstances, dysfunctional microglia can induce detrimental processes leading to the subsequent recruitment of other cell types involved in the innate immune response. This may worsen disease progression by altering synaptic function, ion homeostasis, antioxidant defense and cell survival (Block et al., 2007).

As mentioned before, a broad number of data have shown that alcohol elevates inflammation in the brain, contributing to the impaired neurological function and neurodegeneration associated with alcohol consumption (Yakovleva et al., 2011). From this angle and given their inflammatory properties, microglia arise as crucial players in the onset and progression of alcohol-induced neuronal dysfunction and behavioral abnormalities (Chastain and Sarkar, 2014; Yang et al., 2014; Suk, 2007). Considerable evidence has described that ethanol triggers microglial activation in cell cultures (Fernandez-Lizarbe et al., 2009; Alfonso-Loeches et al., 2010; Boyadjieva and Sarkar, 2010, 2013; Fernandez-Lizarbe et al., 2013; Alfonso-Loeches et al., 2016), animal models (Alfonso-Loeches and Guerri, 2011; McClain et al., 2011; Qin and Crews, 2012a; Zhao et al., 2013; Ahlers et al., 2015; Alfonso-Loeches et al., 2016) and postmortem brains of alcoholics (He and Crews, 2008; Byun et al., 2014; Coleman et al., 2017). Indeed, ethanol increases the number of microglia showing large cell bodies and thick processes characteristic of activated morphology (Nixon et al., 2008; Fernandez-Lizarbe et al., 2009; McClain et al., 2011; Ahlers et al., 2015) and most of these changes are accompanied with elevated expression of pro-inflammatory cytokines, including TNF-α, MCP-1, and IL-1β, as well as neuronal damage (Alfonso-Loeches and Guerri, 2011; Boyadjieva and Sarkar, 2013; Lippai et al., 2013a; Zhao et al., 2013; Byun et al., 2014; Coleman et al., 2017).

A crucial role for microglia-mediated inflammation has been attributed to TLR activation, cytokine production and NF-κB signaling. In particular, TLR4/TLR2 are required for ethanol-induced activation of microglia and subsequent release of IL-1β, TNF-α, MIP-1α, MIP-2, and IL-6 and other inflammatory mediators (NO and free radicals), which in turn, lead to neuronal apoptosis (Fernandez-Lizarbe et al., 2009, 2013; Alfonso-Loeches et al., 2010; Boyadjieva and Sarkar, 2010). Essential for these processes is the upregulation of NF-κB and recruitment of TLR4/TLR2 into the lipid rafts, along with the stimulation of p38 MAP kinase, IRF-3, STAT-1/IRF-1, iNOS, and COX2 pathways (Fernandez-Lizarbe et al., 2009, 2013). Furthermore, in vivo and in vitro ethanol exposure fails to trigger neuroinflammation, microglial activation, myelin alterations and neural death in TLR4 knockout cultures and mice (Fernandez-Lizarbe et al., 2009; Alfonso-Loeches et al., 2010, 2012). On the other hand, although some findings indicate that chronic ethanol exposure does not alter microglial proliferation (Dlugos and Pentney, 2001; Riikonen et al., 2002; Valles et al., 2004), other studies have shown the opposite during alcohol withdrawal and different periods of abstinence (Nixon et al., 2008; Saito et al., 2010; McClain et al., 2011; Zhao et al., 2013; Alfonso-Loeches et al., 2016).

Microglia are a major source of ROS and free radicals at the CNS. Excessive production of these mediators is a major hallmark of postmortem brain tissue from alcoholic people and likely one the major causes of neuroinflammation and activation of signaling cascades that lead to cell damage and further apoptosis (Upadhya et al., 2000; Matsumoto and Matsumoto, 2008). In fact, uncontrolled consumption of alcohol leads to redox imbalance, encompassed by a high production of oxidants and low levels of antioxidants, and functional alterations in several antioxidant enzymes and molecules, including glutathione (GSH), glutathione peroxidase (GSH-Px), superoxide dismutase (SOD), and catalase (Heaton et al., 2003; Boyadjieva and Sarkar, 2013). Changes in these molecules directly correlate with mitochondrial dysfunction and further neuronal damage (Heaton et al., 2003; Boyadjieva and Sarkar, 2013). Following exposure to ethanol, microglia show increased activity of NADPH oxidase (NOX) (Block, 2008). This enzyme regulates the production of ROS in microglia, with potentially significant consequences for neuronal survival (Block, 2008; Choi et al., 2012). Alcohol consumption increases the production of ROS in activated microglia and astrocytes, resulting in impaired neuronal function and cell death (Qin and Crews, 2012b). Complementary studies from Boyadjieva and Sarkar (2013) showed that concentrations of ethanol ≥25 mM induce neuronal apoptosis via microglia and a mechanism involving oxidative stress, since treatment with antioxidant agents (e.g., GSH, catalase, and SOD) successfully suppressed these effects (Boyadjieva and Sarkar, 2013). Given the complex physiology of microglia, beyond doubt, the impact that alcohol may cause on the inflammatory and redox properties of these glial cells will rely on how it is administrated, its concentration and the timeline in where the observations are made.

Neuroinflammation, Oxidative Stress, and Glia-To-Neuron Miscommunication: Implications of Melanocortin System in Alcohol Abuse in Adolescents

Anti-inflammatory Action of Melanocortins and Their Impact on Glial Cells

A substantial body of work has established in vivo and in vitro the anti-inflammatory features of MCs in different systemic and neuroinflammatory models (Catania et al., 2004, 2010; Catania, 2008). Indeed, α-MSH diminishes fever and inflammation in models of acute, chronic, and systemic inflammation (Lipton et al., 1999), whereas similar protective findings have been observed for different brain pathologies, including Alzheimer’s disease (AD) (Giuliani et al., 2014), traumatic brain injury (Schaible et al., 2013), experimental autoimmune encephalomyelitis (Mykicki et al., 2016), and cerebral ischemia (Giuliani et al., 2006). Furthermore, systemic administration of α-MSH abrogates brain inflammation and cytokine expression evoked by cerebral ischemia or LPS (Rajora et al., 1997; Huang and Tatro, 2002), much as α-, β-, and γ-MSH reduced the production of NO, PGE2 during different inflammatory conditions (Weidenfeld et al., 1995; Muceniece et al., 2004; Cragnolini et al., 2006). Albeit MC3R and MC4R expression at the CNS is predominant, until now, diverse lines of evidence indicate that protective effects of MCs depend on the activation of the latter receptor. Pioneering studies by Caruso and colleagues revealed that central administration of α-MSH prevent the LPS-mediated induction of iNOS and COX2 gene expression at the hypothalamic level, an effect that occurred via the activation of MC4Rs (Caruso et al., 2004). Similarly, agonists of MC4Rs counteract neuroinflammation and cell damage (Giuliani et al., 2006, 2014, 2017; Spaccapelo et al., 2011; Liu et al., 2015), whereas its pharmacological blockade or downregulation prevent the neuroprotective effects of α-MSH or its analogs and worse the outcome in different brain disease models (Giuliani et al., 2006; Zhang et al., 2015). While the neuroprotective actions of α-MSH/MC4R pathway are not completely understood, it has been proposed that they are in part exerted by inhibiting the production of inflammatory mediators from glial cells (Caruso et al., 2007). Supporting this idea, both astrocytes and oligodendrocytes exhibit important levels of MC4Rs (Caruso et al., 2007; Selkirk et al., 2007; Benjamins et al., 2013), whereas microglia express all isoforms of MC receptors (Delgado et al., 1998; Lindberg et al., 2005; Benjamins et al., 2013).

In astrocytes, α-MSH increases the production of cAMP and proliferation, as well as morphological features that resemble differentiation (Evans et al., 1984; Zohar and Salomon, 1992). In addition, selective activation of MC4Rs suppress the production of NO and PGE2, as well as the apoptosis triggered by LPS and IFN-γ in astrocytes (Caruso et al., 2007). In the same line, MC-dependent MCR4 stimulation blunts astroglial activation (Aronsson et al., 2006, 2007; Niu) and enhance the expression of BDNF in these glial cells through a cAMP-PKA pathway (Caruso et al., 2012). In the case of microglia, α-MSH inhibits the release of TNF-α, IL-6, and NO (Delgado et al., 1998; Galimberti et al., 1999), while its analogs stimulate the production of the anti-inflammatory cytokines IL-10 and TGF-β from microglia and astrocytes (Carniglia et al., 2013). Recently, Giuliani and coworkers demonstrated that stimulation of MC4Rs prevents the neurodegenerative changes seen in the triple-transgenic (3xTg-AD) mice, an animal model of AD (Giuliani et al., 2014). These responses were associated to decreasing levels of oxidative and nitrosative species, as along with reduction in the phosphorylation of tau protein and modulation of the inflammatory and apoptotic cascades that are implicated in AD (Giuliani et al., 2014).

As mentioned in previous sections, alcohol consumption strongly reduces the expression of α-MSH in the limbic system and hypothalamus (Olney et al., 2014), whereas MC4R activation within the Nac suppress ethanol drinking (Navarro et al., 2011; Lerma-Cabrera et al., 2013b). In spite of this evidence, it is unknown whether alcohol addiction, in particular during the adolescence, occurs due to an imbalance in the inflammatory profile of glial cells caused by low signaling of the MC system. In the next section, we propose a possible mechanism by which lower drive of MC system may increase inflammatory and activated status of glial cells, resulting in impaired glia-to-neuron communication.

Decreased Drive of Melanocortin System and Its Effect on Pro-inflammatory Profile of Glial Cells and Gliotransmission

A new line of evidence suggests that endogenous α-MSH may exert an inhibitory tone on different inflammatory mediators via MC4Rs, acting as a local anti-inflammatory agent within the hypothalamus (Caruso et al., 2004). Supporting this idea, multiple neuroprotective actions of MCs and their analogs reside in the suppression of canonical inflammatory pathways in glial cells such as NF-κB, iNOS, and COX2, a phenomenon that fail when blockade or downregulation of MCRs occurs (Delgado et al., 1998; Galimberti et al., 1999; Caruso et al., 2004, 2007; Giuliani et al., 2006; Spaccapelo et al., 2011). Given that in vitro or in vivo treatment with ethanol augments the inflammatory profile of glial cells, it is plausible speculate that this phenomenon may arise as reflex of decreasing anti-inflammatory drive of the MC system. Indeed, although downregulation of MCRs during ethanol consumption has not been yet truly demonstrated, a substantial body of evidence indicates that ethanol administration reduces the expression of α-MSH in the Arc, CeA, PVT, and LH (Rainero et al., 1990; Kokare et al., 2008; Navarro et al., 2008). Whether reduced α-MSH expression triggered by ethanol could be critical for developing early stages of alcohol addiction and whether this take place due the lacking inhibitory tone of MCs on the inflammatory profile of glial cells remain unknown.

There are some clues that strengthen the potential role of neuroinflammation in the onset and progression of alcohol addiction. For instance, pro-inflammatory molecules, including cytokines and chemokines, reinforce alcohol drinking (Blednov et al., 2012), whereas the opposite is observed when anti-inflammatory molecules are administrated (Blednov et al., 2011). Together these findings argue that pro-inflammatory mediators trigger persistent alcohol intake, which may in turn be the result of deficient α-MSH signaling and subsequent glial inflammation. In line with this, minocycline, a well-known inhibitor of microglial activation and inflammatory mediators, reduces ethanol drinking (Agrawal et al., 2011), while at Nac, astrocytes increase [Ca2+]I, modulating the motivation to self-administer ethanol (Bull et al., 2014). How the decreased drive of MC system is connected to glial inflammation and further reinforcement of alcohol consumption? We believe that downregulation of α-MSH signaling may disturb the inflammatory profile and function of glial cells, resulting in further impaired communication with neurons located in brains areas that are crucial for alcohol rewarding and are more susceptible during adolescence. Different studies have shown that inflammatory mediators disturb intracellular Ca2+ dynamics in glial cells, thus affecting the release of gliotransmitters and further impairing the crosstalk between neurons and glial cells (Ida et al., 2008; Wuchert et al., 2009). Taking into account that glial cells are persistently activated in animal models of alcohol consumption (Yakovleva et al., 2011), it is possible that impairment of intracellular pathways and coordination between glial cells and neurons could play an essential role in brain dysfunction observed in alcohol use disorders.

Recent studies have reviewed the potential impact of astrocytes and microglia in the onset and progression of alcohol disorders (Yang et al., 2014; Adermark and Bowers, 2016). Here we do not overview all of this evidence discussed elsewhere, but rather focus on a particular mechanism of gliotransmission that is known to be altered during inflammatory conditions: the hemichannel-mediated paracrine signaling. Hemichannels are plasma membrane channels constituted by a six-fold ring of connexin monomers and serve as aqueous pores permeable to ions and small molecules, providing a diffusional pathway of exchange between intra- and extracellular compartments (Montero and Orellana, 2015). Connexins are abundantly expressed in brain cells and belong to a highly conserved protein family encoded by 21 genes in humans and 20 in mice, with orthologues in other vertebrate species (Abascal and Zardoya, 2013). In the last decade, another gene family encoding a set of three membrane proteins termed pannexins was identified (Bruzzone et al., 2003). Although connexins and pannexins do not share significant amino acid sequences, they have similar secondary and tertiary structures and most of evidence indicates that pannexins form single membrane channels, similar to connexin hemichannels (Sosinsky et al., 2011). In the normal brain, hemichannels and pannexons mediate the physiological release of gliotransmitters (e.g., ATP, glutamate, D-serine, lactate), serving as crucial players during ischemic tolerance, fear memory consolidation, synaptic transmission, neuronal oscillations and glucose sensing (Cheung et al., 2014). Nevertheless, the uncontrolled opening of these channels seem to be critical to the initiation and maintenance of the homeostatic imbalances that are observed in diverse CNS diseases (Salameh et al., 2013; Orellana et al., 2014a, 2016).

How hemichannels/pannexons could be involved in the miscommunication of glial cell and neurons during ethanol disorders? We speculate that reduced levels of α-MSH caused by ethanol may unlock the tonic inhibition of this neuropeptide on NF-κB pathways, particularly, in glial cells (Figure 2). In this context, the well-known stimulant effect of ethanol in the generation of inflammatory mediators (e.g., cytokines and ROS) could alter the functional state of glial hemichannels and pannexons. According with this line of though, different independent groups have shown that NF-κB-mediated pro-inflammatory mediators promote the opening of hemichannels and pannexons in glial cells. Pioneering observations by Takeuchi et al. (2006) described that TNF-α elicits the release of glutamate via Cx32 hemichannels in microglia, resulting in neuritic beading and neuronal death, while comparable results have been found in human microglial CHME-5 cells (Shaikh et al., 2012). Similarly, TNF-α plus IFN-γ increment the expression of Cx43 and Panx1 in EOC20 microglial cells in conjunction with the activation of hemichannels and pannexons (Sáez et al., 2013). Furthermore, the mixture of TNF-α and IL-1β increases the opening of astroglial Cx43 hemichannels by a mechanism depending on the activation of p38 MAP kinase pathway and further production of NO (Retamal et al., 2007; Abudara et al., 2015). With this in mind, it is reasonable to theorize that glial activation elicited by ethanol may induce the opening of hemichannels and pannexons via autocrine release of cytokines and further stimulation of diverse downstream inflammatory mediators such as NO, prostaglandins, ATP, and ROS. Relevant to this point, increased levels of [Ca2+]i, iNOS, and COX2 activation, as well as production of NO, underpin the Panx1 channel-dependent release of ATP in LPS-stimulated microglia (Orellana et al., 2013), whereas NO-mediated Cx43 s-nitrosylation is pivotal in the activation of astroglial hemichannels triggered by oxidative stress (Retamal et al., 2006). Importantly, the stimulation of these pathways has been linked to glial hemichannel/pannexon activation under different pathological conditions, including amyloid β treatment (Gajardo-Gómez et al., 2017), prenatal inflammation (Avendaño et al., 2015), restraint stress (Orellana et al., 2015), spinal cord injury (Garré et al., 2016), high cholesterol diet (Orellana et al., 2014b), AD (Yi et al., 2016), and Niemann-Pick type C disease (Sáez et al., 2013).

FIGURE 2.

FIGURE 2

The ethanol-induced decrease in α-MSH drive and its impact on glial inflammation and hemichannel/pannexon-dependent gliotransmission. (A) At one end, ethanol reduces the brain levels of α-MSH (1), decreasing the MC4R-mediated anti-inflammatory drive of melanocortin (MC) system on microglia (2). In parallel, ethanol stimulates TLR4Rs (3), resulting in the activation of NF-κβ pathway and further autocrine/paracrine release of TNF-α, (which acts upon its receptor TNFR1 (4). The latter leads to the activation of glutaminase and the consequent release of glutamate through Cx32 hemichannels (HCs) (5). Similarly, NF-κβ signaling promotes the autocrine/paracrine release of IL-1β, which stimulates its receptor as well as accessory proteins (IL1RI and IL1RAcP) (6), resulting in iNOS activation, NO production, COX activation and PGE2 production via unknown mechanisms. PGE2 released by microglia binds to the EP1 metabotropic receptor (not depicted) to elicit Ca2+ release from intracellular stores (7). This release increases [Ca2+]i, which is known to open Cx43 HCs and Panx1 channels (CHs) and subsequently the release glutamate and ATP through them. Furthermore, protein-to-protein interactions between Panx1 CHs and P2X7Rs trigger the signaling that activate the inflammasome (9), perpetuating the cycle of maturation and secretion of pro-inflammatory mediators (e.g., IL-1β), as well as the uncontrolled release of gliotransmitters during ethanol consumption. (B) As with microglia, decreased levels of α-MSH caused by ethanol (1), blunt the MC4R-mediated anti-inflammatory drive of MC system on astrocytes (2). At the same time, ethanol activates TLR4Rs (3) and NF-κβ pathways, establishing the interrelated autocrine/paracrine release of TNF-α (4) and IL-1β (5), similar to what described for microglia. The latter results in the activation of p38 MAP kinase and NO production, as well as the opening of Cx43 hemichannels via s-nitrosylation of Cx43 and release of taurine and glutamate (6). Increases in [Ca2+]i, which is known to open Panx1 CHs may also evoke the release glutamate through them. In addition, pro-inflammatory cytokines released from microglia could potentiate the activation of these pathways, perpetuating the dysfunctional release of gliotransmitters during ethanol consumption (7).)

Because the above inflammatory mediators (cytokines, ROS, NO, ATP) are elevated during alcohol drinking (Fernandez-Lizarbe et al., 2009, 2013; Alfonso-Loeches et al., 2010; Boyadjieva and Sarkar, 2010), their role may be critical for the possible deregulation of hemichannel/pannexon-mediated gliotransmission (Figure 2). An important aspect is the modulatory action that microglia exert on astroglial hemichannel/pannexon activity, which seems to be decisive for neuronal function and survival (Montero and Orellana, 2015; Gajardo-Gómez et al., 2016; Orellana et al., 2016). In fact, microglia subjected to inflammatory conditions release TNF-α and IL-1β, resulting in the further increase of Cx43 hemichannel currents in astrocytes in cell cultures and hippocampal slices (Retamal et al., 2007; Abudara et al., 2015). Interestingly, microglia-evoked Cx43 hemichannel opening allow Ca2+ entry and further release of glutamate, affecting excitatory synaptic activity in the hippocampus (Abudara et al., 2015). In the same manner, the release of ATP via astroglial Cx43 hemichannels and/or Panx1 channels (Braet et al., 2003; Iglesias et al., 2009; Garré et al., 2010) comprises a fundamental signaling through which astrocytes control microglial behavior (Verderio and Matteoli, 2001; Schipke et al., 2002). Acting on P2X7Rs, ATP evokes Ca2+-dependent ATP release in microglia, as acute application of this gliotransmitter induces the opening of Cx43 hemichannels and Panx1 channels in these cells (Bernier et al., 2012; Sáez et al., 2013). Despite of P2X7Rs increase [Ca2+]i (Baroja-Mazo et al., 2013); a well-accepted condition that opens Cx43 hemichannels and Panx1 channels (Locovei et al., 2006; De Bock et al., 2012); the ATP-induced release of ATP linked to Panx1 channel opening imply protein-protein interactions between this pannexon and P2X7Rs (Locovei et al., 2007). Noteworthy, P2X7R-dependent opening of Panx1 channels has been related to the secretion of IL-1β by a mechanism engaging the activation of the inflammasome (Pelegrin and Surprenant, 2006; Kanneganti et al., 2007). Indeed, in neurons and astrocytes, opening of Panx1 channels triggers caspase-1 activation in association with components of the multiprotein inflammasome complex, including the P2X7R (Silverman et al., 2009; Murphy et al., 2012; Minkiewicz et al., 2013). Remarkably, both purinergic receptors and the inflamasome have been shown to be activated by ethanol in vitro and in vivo in glial cells and neurons (Lippai et al., 2013b; Alfonso-Loeches et al., 2014; Wang et al., 2015).

Recent studies have revealed that gliotransmission through hemichannels and pannexons is crucial for synaptic transmission and consolidation of fear and spatial memory (Prochnow et al., 2012; Ardiles et al., 2014; Chever et al., 2014; Walrave et al., 2016). Nevertheless, over activation of these channels has been associated to the release of large amounts of gliotransmitters (e.g., glutamate and ATP), resulting in neuronal dysfunction and even with excitotoxicity. We hypothesize that uncontrolled opening of glial hemichannels and pannexons may be a relevant downstream target that disturbs proper glia-to-neuron communication, affecting synaptic transmission in neural circuits crucial for alcohol rewarding.

Impaired Gliotransmission Mediated by Hemichannels and Pannexons and Its Impact on Neural Circuits Linked to Alcohol Reward in Adolescents

As mentioned in previous sections, the mesocorticolimbic dopamine system, particularly the VTA-NAc circuit, constitutes one of the major neurochemical pathway for reward (Everitt and Robbins, 2005) and alcohol is a well-known elicitor of extracellular dopamine at the NAc (Koob, 2013). During the adolescence, the top–down control of prefrontal cortex over the VTA-NAc circuit is relatively weak, resulting in a chronically VTA-induced activation of NAc (Crews et al., 2007). The latter could be potentiated by synaptic changes evoked by ethanol, especially those originated as cause of impaired gliotransmission. In this context, we believe that uncontrolled opening of hemichannels and pannexons in activated glial cells may enhance the dopaminergic drive of VTA on neurons of the NAc. Indeed, rodents chronically treated with ethanol exhibit increased levels of GFAP (Ortiz et al., 1995) in the VTA, while similar findings have been observed for different microglial inflammatory markers (He and Crews, 2008; Yang et al., 2014). At one end, astroglial hemichannel/pannexon opening potentiated by inflammatory mediators released from microglia, could promote presynaptic glutamate release in the VTA (Figure 3). Supporting this idea, high concentrations of glutamate at the synaptic cleft could be neurotoxic under pathological conditions (Lau and Tymianski, 2010; Ashpole et al., 2013). Importantly, glutamate released through glial hemichannels and pannexons triggers neuronal dysfunction and cell death as result of N-methyl-D-aspartate receptor (NMDAR) activation (Takeuchi et al., 2006; Orellana et al., 2011a,b). Presynaptic glutamate release may also be enhanced by the interaction of NMDARs and Panx1 channels in neurons. In fact, most of the glutamate released from glial hemichannels/pannexons modulate neuronal function by activating Panx1 channels in them (Orellana et al., 2011a,b). How NMDARs do elicit the activity of neuronal pannexons? A possible mechanism involves the phosphorylation of the C-terminal of Panx1 caused by the interaction of NMDARs with Src family kinases (Weilinger et al., 2016). It is possible that glial-induced changes in synaptic transmission at the VTA may relies on intracellular Ca2+ regulation depending on the opening of Panx1 channels in presynaptic and postsynaptic structures (Figure 3).

FIGURE 3.

FIGURE 3

Uncontrolled opening of hemichannels/pannexons and their effect on neuronal circuits that govern ethanol consumption. (A) One mechanism by which glial hemichannels or pannexons may increase ventral tegmental area (VTA) dopaminergic neuron activity and nucleus accumbens (NAc) dopamine (DA) levels involves the synaptic release of glutamate via these channels. Stimulation of NMDARs could then augment VTA dopaminergic activity and trigger the firing of GABAergic neurons in the NAc, increasing alcohol consumption. (B) In addition, increased glutamate released from glial hemichannels and pannexons may enhance DA levels at the NAc by activation of unknown glutamate receptors on presynaptic dopaminergic terminals at the VTA. Potentiated activation of dopaminergic D1or D2 receptors (D1R/D2R) on medium spiny neurons (MSNs) at the NAc may then promote alcohol consumption. (C) Finally, taurine release through astroglial Cx43 hemichannels may activate glycine receptors on MSNs GABAergic neurons, decreasing their inhibitory tone on VTA dopaminergic neurons.

On the other hand, glial cells could increase VTA dopaminergic drive by decreasing inhibitory synapses into VTA. Studies by Molander et al. (2005) revealed that GABAergic neurons at the NAc suppres in a tonic fashion the dopaminergic firing at the VTA via the activation of accumbal glycine receptors (Molander et al., 2005). In a follow-up study, they propose that astrocyte cell swelling evoked by acute ethanol treatment leads to an increase in extracellular taurine, a well-known agonist of glycine receptors (Adermark et al., 2011). An alternative mechanism by which astrocytes could be key players in the increased dopamine concentration in the NAc may reside in the release of taurine through hemichannels (Figure 3), as they have been reported to allow the release of this transmitter (Stridh et al., 2008). Up to now, the only attempt to evaluate the role of hemichannels in alcohol addiction corresponds to Bull and colleagues (Bull et al., 2014). They found that motivation to self-administer ethanol after 3 weeks abstinence was increased following microinjection of mefloquine and 18-a-glycyrrhetinic acid at the NAc, two unspecific and general blockers of gap junction channels, hemichannels and pannexons (D’hondt et al., 2009). Without doubt, the interpretation of these findings in terms of the VTA-NAc circuit is complex, as these blockers have the potential to act in different brain cell types, each of them expressing their own array of connexin and pannexin-based channels. The intracerebral injection in limbic regions of specific mimetic peptides that selectively distinguish hemichannels v/s gap junction channels and pannexons (e.g., Gap19, TAT-L2) will disentangle the contribution of connexins and pannexins in alcohol addiction.

Melanocortin-Dependent Impairment of Glial Cells and its Consequences on Brain and Peripheral Function During Alcoholism

Episodes of adolescent binge drinking could have long-term consequences that will affect not only the circuits involved in alcohol reward, but also those implicated in memory, learning and feeding behavior. The latter may in addition influence and disturb whole body metabolism and energy balance. In the following sections, we discuss in brief how ethanol-induced impairment in MC system may influence synaptic plasticity and peripheral metabolism, in particular, skeletal muscle.

Alcohol Abuse during Adolescence and Synaptic Communication: Possible Role of Melanocortin Networks

Accumulative evidence suggests that prolonged alcohol consumption affects memory and cognitive processes (Zeigler et al., 2005), which are well-established indicators of CNS integrity and function. For instance, hippocampal neurons chronically exposed to ethanol exhibit an increased glutamatergic drive, i.e., increased levels of extracellular glutamate and alterations in its receptors and transporters (Tsai and Coyle, 1998; Krystal et al., 2003). Clinical studies have shown that there is a direct correlation between alcohol dependence and levels of glutamate in the cerebrospinal fluid (CSF) (Umhau et al., 2010). An imbalance in glutamate levels can affect the dynamics of glutamate receptors, however, alcohol can also directly affect the activity of glutamate receptors. Specific alterations in NMDARs include perturbations in the direct occupancy of receptors, alterations in gating, as well as changes in the phosphorylation and activation states of NMDARs (Lovinger et al., 1989; Woodward, 2000). Moreover, alcohol can also influence α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) by inducing an increase in their expression and localization (Chen et al., 1999; Christian et al., 2012). In the mammalian CNS, both AMPARs and NMDARs mainly mediate fast excitatory neurotransmission, and participate directly in the control of synaptic transmission and plasticity (Traynelis et al., 2010).

The Rosetta stone of synaptic plasticity is LTP. This phenomenon entails a long-lasting enhancement of synaptic transmission between two neurons after high frequency stimulation, which results in the strengthening of neuronal synapses (Bliss and Collingridge, 1993). Notably, ethanol exposure dramatically blunts the induction of LTP (Givens and McMahon, 1995; White et al., 2000) and induces loss of hippocampal-dependent memory (Melia et al., 1996). How do MCs participate in the ethanol-induced alterations in synaptic plasticity? Several extracellular factors, including MC peptides such as α-MSH and their receptors (e.g., MC4R), modulate hippocampal synaptic transmission (Shen et al., 2013). In fact, d-Tyr-MTII, an agonist of MC4Rs, increases LTP in hippocampal slices by a mechanism involving the PKA-dependent insertion of AMPARs into presynaptic sites (Shen et al., 2013). PKA is an important target of MC4Rs and is a key player in plasticity-related events (Abel and Nguyen, 2008). Alcohol-mediated alterations in NMDARs and their function in synaptic plasticity is likely to have a structural basis. Chronic administration of ethanol decreases neuronal spine density, in particular that in mature cells (Korkotian et al., 2015). Importantly, downregulation of MC4Rs dramatically abolishes the increase in mature spines triggered by d-Tyr MTII (Shen et al., 2013), suggesting the possibility that ethanol-induced structural synaptic changes may involve impairments in MC4Rs. Further studies are needed to understand the underlying basis by which ethanol influences synaptic transmission, and whether glial cells play a role in this process.

Heavy Drinking in Adolescents and Melanocortin-dependent Control of Whole Body Metabolism: Focus on Skeletal Muscle

Skeletal muscle is a dynamic and highly plastic tissue that adapts to various external stimuli (e.g., contractile activity, loading conditions and substrate supply) to match structural, functional, and metabolic demands (Bassel-Duby and Olson, 2006). This tissue plays a critical role in glycemic control and metabolic homeostasis, and is the predominant site of glucose disposal under insulin-stimulated conditions (DeFronzo et al., 1981). In this context, exercise increases skeletal muscle glucose uptake via an insulin-independent pathway (Lee et al., 1995), indicating that muscle contraction directly impacts on glucose homeostasis, and increases insulin sensitivity and glucose uptake in skeletal muscle fibers (Pereira and Lancha, 2004; Holloszy, 2005; Rose and Richter, 2005). Glucose uptake is important for the actions of both exercise and insulin at skeletal muscle fibers (Sakamoto et al., 2002; Pereira and Lancha, 2004). Each stimulus results in the redistribution of the glucose transporter type 4 (GLUT4) from intracellular vesicles to the sarcolemma, increasing the rate of glucose uptake into muscle fibers (Douen et al., 1990; McCarthy and Elmendorf, 2007; Foley et al., 2011).

Alcohol has profound effects on muscle and whole-body fuel metabolism, thus contributing to increased morbidity and mortality in people with alcohol dependence (Steiner et al., 2015). In fact, alcohol abuse increases the synthesis and secretion of various catabolic agents, such as inflammatory cytokines and glucocorticoids, as well as the production of oxidative metabolites generated by the hepatic metabolism of ethanol (Avogaro and Tiengo, 1993; Gonzalez-Reimers et al., 2011). Interestingly, Molina and colleagues found differential glucose uptake in muscles from rats exposed to alcohol (Molina et al., 1991), whereas studies carried out in healthy people show that alcohol acutely decreases insulin-stimulated whole-body glucose uptake (Yki-Jarvinen and Nikkila, 1985; Avogaro et al., 1987; Avogaro et al., 1996). While there is no consensus about the mechanism underlying alcohol-induced insulin resistance, it appears that alcohol may alter the actions of insulin at a number of key regulatory steps, including PI3K/Akt signaling pathways and/or GLUT4 translocation (Wasserman, 2009). For instance, alcohol intake reduces GLUT4 protein in the plasma membrane fraction of the gastrocnemius, but not in whole muscle homogenate from rats (Wilkes and Nagy, 1996; Lang et al., 2014). Similarly, in vitro incubation of myotubes with alcohol acutely inhibits insulin-stimulated GLUT4 translocation (Yu et al., 2000).

The brain regulates most energy metabolism in muscle (Braun and Marks, 2011), however, whether alcohol-induced impairment in muscle energetics and peripheral metabolism occurs as result of alterations in central neuronal circuits has not yet been examined. Energy homeostasis, the balance between caloric intake and energy expenditure, is regulated by the neuroendocrine and autonomic systems which are both controlled by the CNS. Specific neuronal circuits located in the hypothalamus and brain-stem continuously monitor signals reflecting energy status, and initiate appropriate behavioral and metabolic responses to deal with nutrient availability (Seeley and Woods, 2003; Lam et al., 2005; Plum et al., 2006). One of these networks is the MC system, which governs and modulates nutrient intake and energy metabolism (Williams et al., 2011; Edenberg and Foroud, 2013). MC3Rs and MC4Rs are the most relevant receptors involved in the regulation of energy homeostasis in different tissues (Fan et al., 1997), including skeletal muscle (Gavini et al., 2016). Recently, Gavini et al. (2016) found that the activation of MC receptors in the VMH increased heat dissipation in the gastrocnemius muscle during controlled activity, as well as augmenting skeletal muscle norepinephrine turnover and the expression of mediators of muscle energy. Furthermore, MC receptors play a critical role in appetite control and body-weight regulation, and are involved in obesity and diabetes mellitus type 2 (DM2; Cone, 1999; Nogueiras et al., 2007). In rodent models, activation of MC4Rs (Nargund et al., 2006) or ablation of AgRP/NPY-coexpressing neurons (Bewick et al., 2005; Gropp et al., 2005; Luquet et al., 2005; Ste Marie et al., 2005) results in anorexia and weight loss, whereas downregulation of MC3Rs, or the removal of agonist-producing neurons, leads to hyperphagia and obesity (Huszar et al., 1997; Chen et al., 2000). The role of MC3Rs in energy homeostasis is unclear, however, they may be one of the major receptors responsible for the anti-inflammatory properties of MC peptides, and perhaps owing to this role may influence energy homeostasis (Mountjoy, 2010a,b). Of relevance to this point is the fact that both obesity and DM2 are associated with chronic low-grade inflammation, caused by an imbalance between pro- and anti-inflammatory cytokines.

Complementary studies in patients (Festa et al., 2000; Calder et al., 2011; Donath and Shoelson, 2011) showed that blockade of central MC4R signaling promotes insulin resistance in skeletal muscle (Mountjoy, 2010b). Furthermore, loss-of-function mutations in MC4Rs are associated with hyperphagia, severe early onset obesity, hyperinsulinemia, and increased lean mass (Vaisse et al., 1998, 2000; Yeo et al., 1998; Farooqi et al., 2003; Yeo et al., 2003; Biebermann et al., 2006). Similar effects have also been observed in studies with MC4R knockout mice (Huszar et al., 1997). These findings support an important role for the MC system in whole-body and muscle energy homeostasis across mammalian species. Thus, MCs and their receptors could be one of the major ways by which ethanol exerts its effects on metabolism and muscle in people with alcohol dependence. In fact, neuronal networks that sustain MC signaling are major targets for crucial endocrine messengers and hormones that control energy demands and body weight, including leptin, insulin, cholecystokinin, and ghrelin (Moran, 2004; Cone, 2005; Aja and Moran, 2006; Harrold and Williams, 2006; Moran, 2006; Xu and Barsh, 2006). Indeed, the crucial mechanisms by which insulin and leptin govern energy homeostasis are determined by their influence on hypothalamic POMC or AgRP neurons (Varela and Horvath, 2012). For example, the actions of insulin in AgRP neurons reduces gluconeogenesis in the liver, but in POMC neurons has an inverse effect, favoring energy expenditure in an MC-dependent manner (Lin et al., 2010). In the same manner, the MC system directly controls hepatic glucose metabolism (Obici et al., 2001), and thermogenesis in brown adipose tissue (Voss-Andreae et al., 2007) and skeletal muscle (Gavini et al., 2016), revealing the existence of direct neuroendocrine control of MCs over peripheral cell metabolism.

Conclusion and Future Directions

Decreased α-MSH drive, glial inflammation, increased hemichannel, and pannexon opening, and over activation of VTA-Nac circuit may constitute an interdependent cyclic process during heavy alcohol drinking. The latter could be potentiated during adolescence and thereby, whether interruption of any of these steps can ameliorate the cascade of events that lead to alcohol addiction could be crucial to interrupt further chronic alcoholism in adults. Because ethanol-induced decrease in α-MSH drive may potentiates glial inflammation in other brain areas including the hippocampus and hypothalamus, its impact on synaptic transmission and memory, as well as whole body metabolism and energy expenditure could be critical to ameliorate the major devastating effect of heavy drinking. Accordingly, the different components of MC system may serve as potential targets for therapeutic interventions in alcohol abuse among adolescents and later in the adulthood. Nevertheless, further studies are required to determine how gliotransmission mediated by hemichannels and pannexons contributes to ethanol addiction and drinking behaviors.

Author Contributions

JAO: Conceived Idea, wrote paper and some illustrations; WC: Conceived idea, wrote paper; MC: Conceived idea and wrote the paper; JL: Conceived the idea and wrote some parts of the paper; EK: wrote the paper; CO-F: Conceived idea and wrote some parts of the paper; RQ: Conceived the idea, wrote the paper and revised final version.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

This work was supported by Comisión Nacional de Investigación Científica y Tecnológica (CONICYT) and Programa de Investigación Asociativa (PA): Grant Anillo de Ciencia y Tecnología ACT1411; Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT): Grant 11121133 and 1160710 (to JAO); 11121206 (to WC); 1140284 (to FC and JMLC); 11130424 (to CO-F); 1150850 (to EK); and 1140968 and 1170441 (to RQ); Proyecto de Cooperación Internacional (PCI), BMBF 20150065 (to WC).

References

  1. Abascal F., Zardoya R. (2013). Evolutionary analyses of gap junction protein families. Biochim. Biophys. Acta 1828 4–14. 10.1016/j.bbamem.2012.02.007 [DOI] [PubMed] [Google Scholar]
  2. Abel T., Nguyen P. V. (2008). Regulation of hippocampus-dependent memory by cyclic AMP-dependent protein kinase. Prog. Brain Res. 169 97–115. 10.1016/S0079-6123(07)00006-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Abudara V., Roux L., Dallerac G., Matias I., Dulong J., Mothet J. P., et al. (2015). Activated microglia impairs neuroglial interaction by opening Cx43 hemichannels in hippocampal astrocytes. Glia 63 795–811. 10.1002/glia.22785 [DOI] [PubMed] [Google Scholar]
  4. Adermark L., Bowers M. S. (2016). Disentangling the role of astrocytes in alcohol use disorder. Alcohol. Clin. Exp. Res. 40 1802–1816. 10.1111/acer.13168 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Adermark L., Clarke R. B., Olsson T., Hansson E., Soderpalm B., Ericson M. (2011). Implications for glycine receptors and astrocytes in ethanol-induced elevation of dopamine levels in the nucleus accumbens. Addict. Biol. 16 43–54. 10.1111/j.1369-1600.2010.00206.x [DOI] [PubMed] [Google Scholar]
  6. Adermark L., Lovinger D. M. (2006). Ethanol effects on electrophysiological properties of astrocytes in striatal brain slices. Neuropharmacology 51 1099–1108. 10.1016/j.neuropharm.2006.05.035 [DOI] [PubMed] [Google Scholar]
  7. Adermark L., Olsson T., Hansson E. (2004). Ethanol acutely decreases astroglial gap junction permeability in primary cultures from defined brain regions. Neurochem. Int. 45 971–978. 10.1016/j.neuint.2004.06.007 [DOI] [PubMed] [Google Scholar]
  8. Agrawal R. G., Hewetson A., George C. M., Syapin P. J., Bergeson S. E. (2011). Minocycline reduces ethanol drinking. Brain Behav. Immun. 25 S165–S169. 10.1016/j.bbi.2011.03.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ahlers K. E., Karacay B., Fuller L., Bonthius D. J., Dailey M. E. (2015). Transient activation of microglia following acute alcohol exposure in developing mouse neocortex is primarily driven by BAX-dependent neurodegeneration. Glia 63 1694–1713. 10.1002/glia.22835 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Aja S., Moran T. H. (2006). Recent advances in obesity: adiposity signaling and fat metabolism in energy homeostasis. Adv. Psychosom. Med. 27 1–23. 10.1159/000090959 [DOI] [PubMed] [Google Scholar]
  11. Alfonso-Loeches S., Guerri C. (2011). Molecular and behavioral aspects of the actions of alcohol on the adult and developing brain. Crit. Rev. Clin. Lab. Sci. 48 19–47. 10.3109/10408363.2011.580567 [DOI] [PubMed] [Google Scholar]
  12. Alfonso-Loeches S., Pascual M., Gomez-Pinedo U., Pascual-Lucas M., Renau-Piqueras J., Guerri C. (2012). Toll-like receptor 4 participates in the myelin disruptions associated with chronic alcohol abuse. Glia 60 948–964. 10.1002/glia.22327 [DOI] [PubMed] [Google Scholar]
  13. Alfonso-Loeches S., Pascual-Lucas M., Blanco A. M., Sanchez-Vera I., Guerri C. (2010). Pivotal role of TLR4 receptors in alcohol-induced neuroinflammation and brain damage. J. Neurosci. 30 8285–8295. 10.1523/JNEUROSCI.0976-10.2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Alfonso-Loeches S., Urena-Peralta J., Morillo-Bargues M. J., Gomez-Pinedo U., Guerri C. (2016). Ethanol-Induced TLR4/NLRP3 neuroinflammatory response in microglial cells promotes leukocyte infiltration across the BBB. Neurochem. Res. 41 193–209. 10.1007/s11064-015-1760-5 [DOI] [PubMed] [Google Scholar]
  15. Alfonso-Loeches S., Urena-Peralta J. R., Morillo-Bargues M. J., Oliver-De La Cruz J., Guerri C. (2014). Role of mitochondria ROS generation in ethanol-induced NLRP3 inflammasome activation and cell death in astroglial cells. Front. Cell Neurosci. 8:216 10.3389/fncel.2014.00216 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Alhaddad H., Kim N. T., Aal-Aaboda M., Althobaiti Y. S., Leighton J., Boddu S. H., et al. (2014). Effects of MS-153 on chronic ethanol consumption and GLT1 modulation of glutamate levels in male alcohol-preferring rats. Front. Behav. Neurosci. 8:366 10.3389/fnbeh.2014.00366 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Allansson L., Khatibi S., Olsson T., Hansson E. (2001). Acute ethanol exposure induces [Ca2+]i transients, cell swelling and transformation of actin cytoskeleton in astroglial primary cultures. J. Neurochem. 76 472–479. 10.1046/j.1471-4159.2001.00097.x [DOI] [PubMed] [Google Scholar]
  18. Allen C. D., Rivier C. L., Lee S. Y. (2011). Adolescent alcohol exposure alters the central brain circuits known to regulate the stress response. Neuroscience 182 162–168. 10.1016/j.neuroscience.2011.03.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Arain M., Haque M., Johal L., Mathur P., Nel W., Rais A., et al. (2013). Maturation of the adolescent brain. Neuropsychiatr. Dis. Treat. 9 449–461. 10.2147/NDT.S39776 [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ardiles A. O., Flores-Munoz C., Toro-Ayala G., Cardenas A. M., Palacios A. G., Munoz P., et al. (2014). Pannexin 1 regulates bidirectional hippocampal synaptic plasticity in adult mice. Front. Cell Neurosci. 8:326 10.3389/fncel.2014.00326 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Aronsson A. F., Spulber S., Oprica M., Winblad B., Post C., Schultzberg M. (2007). Alpha-MSH rescues neurons from excitotoxic cell death. J. Mol. Neurosci. 33 239–251. 10.1007/s12031-007-0019-2 [DOI] [PubMed] [Google Scholar]
  22. Aronsson A. F., Spulber S., Popescu L. M., Winblad B., Post C., Oprica M., et al. (2006). alpha-melanocyte-stimulating hormone is neuroprotective in rat global cerebral ischemia. Neuropeptides 40 65–75. 10.1016/j.npep.2005.10.006 [DOI] [PubMed] [Google Scholar]
  23. Aschner M., Allen J. W., Mutkus L. A., Cao C. (2001a). Ethanol-induced swelling in neonatal rat primary astrocyte cultures. Brain Res. 900 219–226. [DOI] [PubMed] [Google Scholar]
  24. Aschner M., Mutkus L. A., Allen J. W. (2001b). Amino acid uptake and release in primary astrocyte cultures exposed to ethanol. Ann. N. Y. Acad. Sci. 939 23–27. 10.1111/j.1749-6632.2001.tb03607.x [DOI] [PubMed] [Google Scholar]
  25. Ashpole N. M., Chawla A. R., Martin M. P., Brustovetsky T., Brustovetsky N., Hudmon A. (2013). Loss of calcium/calmodulin-dependent protein kinase II activity in cortical astrocytes decreases glutamate uptake and induces neurotoxic release of ATP. J. Biol. Chem. 288 14599–14611. 10.1074/jbc.M113.466235 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Avendaño B. C., Montero T. D., Chavez C. E., Von Bernhardi R., Orellana J. A. (2015). Prenatal exposure to inflammatory conditions increases Cx43 and Panx1 unopposed channel opening and activation of astrocytes in the offspring effect on neuronal survival. Glia. 10.1002/glia.22877 [Epub ahead of print]. [DOI] [PubMed] [Google Scholar]
  27. Avogaro A., Fontana P., Valerio A., Trevisan R., Riccio A., Del Prato S., et al. (1987). Alcohol impairs insulin sensitivity in normal subjects. Diabetes Res. 5 23–27. [PubMed] [Google Scholar]
  28. Avogaro A., Tiengo A. (1993). Alcohol, glucose metabolism and diabetes. Diabetes Metab. Rev. 9 129–146. 10.1002/dmr.5610090205 [DOI] [PubMed] [Google Scholar]
  29. Avogaro A., Valerio A., Miola M., Crepaldi C., Pavan P., Tiengo A., et al. (1996). Ethanol impairs insulin-mediated glucose uptake by an indirect mechanism. J. Clin. Endocrinol. Metab. 81 2285–2290. [DOI] [PubMed] [Google Scholar]
  30. Ayers-Ringler J. R., Oliveros A., Qiu Y. Y., Lindberg D. M., Hinton D. J., Moore R. M., et al. (2016). Label-free proteomic analysis of protein changes in the striatum during chronic ethanol use and early withdrawal. Front. Behav. Neurosci. 10:46 10.3389/fnbeh.2016.00046 [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Baroja-Mazo A., Barbera-Cremades M., Pelegrin P. (2013). The participation of plasma membrane hemichannels to purinergic signaling. Biochim. Biophys. Acta 1828 79–93. 10.1016/j.bbamem.2012.01.002 [DOI] [PubMed] [Google Scholar]
  32. Barres B. A. (2008). The mystery and magic of glia: a perspective on their roles in health and disease. Neuron 60 430–440. 10.1016/j.neuron.2008.10.013 [DOI] [PubMed] [Google Scholar]
  33. Barson J. R., Carr A. J., Soun J. E., Sobhani N. C., Rada P., Leibowitz S. F., et al. (2010). Opioids in the hypothalamic paraventricular nucleus stimulate ethanol intake. Alcohol. Clin. Exp. Res. 34 214–222. 10.1111/j.1530-0277.2009.01084.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Barson J. R., Leibowitz S. F. (2016). Hypothalamic neuropeptide signaling in alcohol addiction. Prog. Neuropsychopharmacol. Biol. Psychiatry 65 321–329. 10.1016/j.pnpbp.2015.02.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Bassel-Duby R., Olson E. N. (2006). Signaling pathways in skeletal muscle remodeling. Annu. Rev. Biochem. 75 19–37. 10.1146/annurev.biochem.75.103004.142622 [DOI] [PubMed] [Google Scholar]
  36. Bechara A. (2005). Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective. Nat. Neurosci. 8 1458–1463. 10.1038/nn1584 [DOI] [PubMed] [Google Scholar]
  37. Benjamins J. A., Nedelkoska L., Bealmear B., Lisak R. P. (2013). ACTH protects mature oligodendroglia from excitotoxic and inflammation-related damage in vitro. Glia 61 1206–1217. 10.1002/glia.22504 [DOI] [PubMed] [Google Scholar]
  38. Bernier L. P., Ase A. R., Boue-Grabot E., Seguela P. (2012). P2X4 receptor channels form large noncytolytic pores in resting and activated microglia. Glia 60 728–737. 10.1002/glia.22301 [DOI] [PubMed] [Google Scholar]
  39. Bewick G. A., Gardiner J. V., Dhillo W. S., Kent A. S., White N. E., Webster Z., et al. (2005). Post-embryonic ablation of AgRP neurons in mice leads to a lean, hypophagic phenotype. FASEB J. 19 1680–1682. [DOI] [PubMed] [Google Scholar]
  40. Biebermann H., Castaneda T. R., Van Landeghem F., Von Deimling A., Escher F., Brabant G., et al. (2006). A role for beta-melanocyte-stimulating hormone in human body-weight regulation. Cell Metab. 3 141–146. 10.1016/j.cmet.2006.01.007 [DOI] [PubMed] [Google Scholar]
  41. Blanc E. M., Bruce-Keller A. J., Mattson M. P. (1998). Astrocytic gap junctional communication decreases neuronal vulnerability to oxidative stress-induced disruption of Ca2+ homeostasis and cell death. J. Neurochem. 70 958–970. 10.1046/j.1471-4159.1998.70030958.x [DOI] [PubMed] [Google Scholar]
  42. Blanco A. M., Guerri C. (2007). Ethanol intake enhances inflammatory mediators in brain: role of glial cells and TLR4/IL-1RI receptors. Front. Biosci. 12:2616–2630. 10.2741/2259 [DOI] [PubMed] [Google Scholar]
  43. Blanco A. M., Pascual M., Valles S. L., Guerri C. (2004). Ethanol-induced iNOS and COX-2 expression in cultured astrocytes via NF-kappa B. Neuroreport 15 681–685. 10.1097/00001756-200403220-00021 [DOI] [PubMed] [Google Scholar]
  44. Blanco A. M., Perez-Arago A., Fernandez-Lizarbe S., Guerri C. (2008). Ethanol mimics ligand-mediated activation and endocytosis of IL-1RI/TLR4 receptors via lipid rafts caveolae in astroglial cells. J. Neurochem. 106 625–639. 10.1111/j.1471-4159.2008.05425.x [DOI] [PubMed] [Google Scholar]
  45. Blanco A. M., Valles S. L., Pascual M., Guerri C. (2005). Involvement of TLR4/type IIL-1 receptor signaling in the induction of inflammatory mediators and cell death induced by ethanol in cultured astrocytes. J. Immunol. 175 6893–6899. 10.4049/jimmunol.175.10.6893 [DOI] [PubMed] [Google Scholar]
  46. Blednov Y. A., Benavidez J. M., Geil C., Perra S., Morikawa H., Harris R. A. (2011). Activation of inflammatory signaling by lipopolysaccharide produces a prolonged increase of voluntary alcohol intake in mice. Brain Behav. Immun. 25(Suppl. 1) S92–S105. 10.1016/j.bbi.2011.01.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Blednov Y. A., Ponomarev I., Geil C., Bergeson S., Koob G. F., Harris R. A. (2012). Neuroimmune regulation of alcohol consumption: behavioral validation of genes obtained from genomic studies. Addict. Biol. 17 108–120. 10.1111/j.1369-1600.2010.00284.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Bliss T. V., Collingridge G. L. (1993). A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361 31–39. 10.1038/361031a0 [DOI] [PubMed] [Google Scholar]
  49. Bloch B., Bugnon C., Fellmann D., Lenys D., Gouget A. (1979). Neurons of the rat hypothalamus reactive with antisera against endorphins, ACTH, MSH and beta-LPH. Cell Tissue Res. 204 1–15. 10.1007/BF00235160 [DOI] [PubMed] [Google Scholar]
  50. Block M. L. (2008). NADPH oxidase as a therapeutic target in Alzheimer’s disease. BMC Neurosci. 9(Suppl. 2):S8 10.1186/1471-2202-9-S2-S8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Block M. L., Zecca L., Hong J. S. (2007). Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 8 57–69. 10.1038/nrn2038 [DOI] [PubMed] [Google Scholar]
  52. Boyadjieva N. I., Sarkar D. K. (2010). Role of microglia in ethanol’s apoptotic action on hypothalamic neuronal cells in primary cultures. Alcohol. Clin. Exp. Res. 34 1835–1842. 10.1111/j.1530-0277.2010.01271.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Boyadjieva N. I., Sarkar D. K. (2013). Microglia play a role in ethanol-induced oxidative stress and apoptosis in developing hypothalamic neurons. Alcohol. Clin. Exp. Res. 37 252–262. 10.1111/j.1530-0277.2012.01889.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Braet K., Vandamme W., Martin P. E., Evans W. H., Leybaert L. (2003). Photoliberating inositol-1,4,5-trisphosphate triggers ATP release that is blocked by the connexin mimetic peptide gap 26. Cell Calcium 33 37–48. 10.1016/S0143-4160(02)00180-X [DOI] [PubMed] [Google Scholar]
  55. Braun T. P., Marks D. L. (2011). Hypothalamic regulation of muscle metabolism. Curr. Opin. Clin. Nutr. Metab. Care 14 237–242. 10.1097/MCO.0b013e328345bbcd [DOI] [PubMed] [Google Scholar]
  56. Brown S. A., Tapert S. F. (2004). Adolescence and the trajectory of alcohol use: basic to clinical studies. Ann. N. Y. Acad. Sci. 1021 234–244. 10.1196/annals.1308.028 [DOI] [PubMed] [Google Scholar]
  57. Bruzzone R., Hormuzdi S. G., Barbe M. T., Herb A., Monyer H. (2003). Pannexins, a family of gap junction proteins expressed in brain. Proc. Natl. Acad. Sci. U.S.A. 100 13644–13649. 10.1073/pnas.2233464100 [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Bull C., Freitas K. C., Zou S., Poland R. S., Syed W. A., Urban D. J., et al. (2014). Rat nucleus accumbens core astrocytes modulate reward and the motivation to self-administer ethanol after abstinence. Neuropsychopharmacology 39 2835–2845. 10.1038/npp.2014.135 [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Bull C., Syed W. A., Minter S. C., Bowers M. S. (2015). Differential response of glial fibrillary acidic protein-positive astrocytes in the rat prefrontal cortex following ethanol self-administration. Alcohol. Clin. Exp. Res. 39 650–658. 10.1111/acer.12683 [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Byun K., Bayarsaikhan D., Bayarsaikhan E., Son M., Oh S., Lee J., et al. (2014). Microglial AGE-albumin is critical in promoting alcohol-induced neurodegeneration in rats and humans. PLoS ONE 9:e104699 10.1371/journal.pone.0104699 [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Caballero A., Granberg R., Tseng K. Y. (2016). Mechanisms contributing to prefrontal cortex maturation during adolescence. Neurosci. Biobehav. Rev. 70 4–12. 10.1016/j.neubiorev.2016.05.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Calder P. C., Ahluwalia N., Brouns F., Buetler T., Clement K., Cunningham K., et al. (2011). Dietary factors and low-grade inflammation in relation to overweight and obesity. Br. J. Nutr. 106(Suppl. 3) S5–S78. 10.1017/S0007114511005460 [DOI] [PubMed] [Google Scholar]
  63. Carniglia L., Durand D., Caruso C., Lasaga M. (2013). Effect of NDP-alpha-MSH on PPAR-gamma and -beta expression and anti-inflammatory cytokine release in rat astrocytes and microglia. PLoS ONE 8:e57313 10.1371/journal.pone.0057313 [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Caruso C., Carniglia L., Durand D., Gonzalez P. V., Scimonelli T. N., Lasaga M. (2012). Melanocortin 4 receptor activation induces brain-derived neurotrophic factor expression in rat astrocytes through cyclic AMP–Protein kinase A pathway. Mol. Cell. Endocrinol. 348 47–54. 10.1016/j.mce.2011.07.036 [DOI] [PubMed] [Google Scholar]
  65. Caruso C., Durand D., Schioth H. B., Rey R., Seilicovich A., Lasaga M. (2007). Activation of melanocortin 4 receptors reduces the inflammatory response and prevents apoptosis induced by lipopolysaccharide and interferon-gamma in astrocytes. Endocrinology 148 4918–4926. 10.1210/en.2007-0366 [DOI] [PubMed] [Google Scholar]
  66. Caruso C., Mohn C., Karara A. L., Rettori V., Watanobe H., Schioth H. B., et al. (2004). Alpha-melanocyte-stimulating hormone through melanocortin-4 receptor inhibits nitric oxide synthase and cyclooxygenase expression in the hypothalamus of male rats. Neuroendocrinology 79 278–286. 10.1159/000079321 [DOI] [PubMed] [Google Scholar]
  67. Catania A. (2008). Neuroprotective actions of melanocortins: a therapeutic opportunity. Trends Neurosci. 31 353–360. 10.1016/j.tins.2008.04.002 [DOI] [PubMed] [Google Scholar]
  68. Catania A., Gatti S., Colombo G., Lipton J. M. (2004). Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol. Rev. 56 1–29. 10.1124/pr.56.1.1 [DOI] [PubMed] [Google Scholar]
  69. Catania A., Lonati C., Sordi A., Carlin A., Leonardi P., Gatti S. (2010). The melanocortin system in control of inflammation. ScientificWorldJournal 10 1840–1853. 10.1100/tsw.2010.173 [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Center for Disease Control (2013). National Center for Health Statistics. Health, United States, 2013: With Special Feature on Prescription Drugs. Hyattsville, MD: Center for Disease Control. [Google Scholar]
  71. Chai B. X., Neubig R. R., Millhauser G. L., Thompson D. A., Jackson P. J., Barsh G. S., et al. (2003). Inverse agonist activity of agouti and agouti-related protein. Peptides 24 603–609. 10.1016/S0196-9781(03)00104-9 [DOI] [PubMed] [Google Scholar]
  72. Chastain L. G., Sarkar D. K. (2014). Role of microglia in regulation of ethanol neurotoxic action. Int. Rev. Neurobiol. 118 81–103. 10.1016/B978-0-12-801284-0.00004-X [DOI] [PubMed] [Google Scholar]
  73. Chen A. S., Marsh D. J., Trumbauer M. E., Frazier E. G., Guan X. M., Yu H., et al. (2000). Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat. Genet. 26 97–102. 10.1038/79254 [DOI] [PubMed] [Google Scholar]
  74. Chen F., Jarrott B., Lawrence A. J. (1999). Up-regulation of cortical AMPA receptor binding in the fawn-hooded rat following ethanol withdrawal. Eur. J. Pharmacol. 384 139–146. 10.1016/S0014-2999(99)00675-5 [DOI] [PubMed] [Google Scholar]
  75. Cheung G., Chever O., Rouach N. (2014). Connexons and pannexons: newcomers in neurophysiology. Front. Cell. Neurosci. 8:348 10.3389/fncel.2014.00348 [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Chever O., Lee C. Y., Rouach N. (2014). Astroglial connexin43 hemichannels tune basal excitatory synaptic transmission. J. Neurosci. 34 11228–11232. 10.1523/JNEUROSCI.0015-14.2014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Choi S. H., Aid S., Kim H. W., Jackson S. H., Bosetti F. (2012). Inhibition of NADPH oxidase promotes alternative and anti-inflammatory microglial activation during neuroinflammation. J. Neurochem. 120 292–301. 10.1111/j.1471-4159.2011.07572.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Christian D. T., Alexander N. J., Diaz M. R., Robinson S., Mccool B. A. (2012). Chronic intermittent ethanol and withdrawal differentially modulate basolateral amygdala AMPA-type glutamate receptor function and trafficking. Neuropharmacology 62 2430–2439. 10.1016/j.neuropharm.2012.02.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Coleman L. G., Jr., Zou J., Crews F. T. (2017). Microglial-derived miRNA let-7 and HMGB1 contribute to ethanol-induced neurotoxicity via TLR7. J. Neuroinflammation 14 22 10.1186/s12974-017-0799-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Cone R. D. (1999). The central melanocortin system and energy homeostasis. Trends Endocrinol. Metab. 10 211–216. 10.1016/S1043-2760(99)00153-8 [DOI] [PubMed] [Google Scholar]
  81. Cone R. D. (2005). Anatomy and regulation of the central melanocortin system. Nat. Neurosci. 8 571–578. 10.1038/nn1455 [DOI] [PubMed] [Google Scholar]
  82. Cragnolini A. B., Caruso C., Lasaga M., Scimonelli T. N. (2006). Alpha-MSH and gamma-MSH modulate early release of hypothalamic PGE2 and NO induced by IL-1beta differently. Neurosci. Lett. 409 168–172. 10.1016/j.neulet.2006.09.034 [DOI] [PubMed] [Google Scholar]
  83. Crews F., He J., Hodge C. (2007). Adolescent cortical development: a critical period of vulnerability for addiction. Pharmacol. Biochem. Behav. 86 189–199. 10.1016/j.pbb.2006.12.001 [DOI] [PubMed] [Google Scholar]
  84. Crews F. T., Braun C. J., Hoplight B., Switzer R. C., III., Knapp D. J. (2000). Binge ethanol consumption causes differential brain damage in young adolescent rats compared with adult rats. Alcohol. Clin. Exp. Res. 24 1712–1723. 10.1111/j.1530-0277.2000.tb01973.x [DOI] [PubMed] [Google Scholar]
  85. Cubero I., Navarro M., Carvajal F., Lerma-Cabrera J. M., Thiele T. E. (2010). Ethanol-induced increase of agouti-related protein (AgRP) immunoreactivity in the arcuate nucleus of the hypothalamus of C57BL/6J, but not 129/SvJ, inbred mice. Alcohol. Clin. Exp. Res. 34 693–701. 10.1111/j.1530-0277.2009.01138.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Cui C., Shurtleff D., Harris R. A. (2014). Neuroimmune mechanisms of alcohol and drug addiction. Int. Rev. Neurobiol. 118 1–12. 10.1016/B978-0-12-801284-0.00001-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Dalcik H., Yardimoglu M., Filiz S., Gonca S., Dalcik C., Erden B. F. (2009). Chronic ethanol-induced glial fibrillary acidic protein (GFAP) immunoreactivity: an immunocytochemical observation in various regions of adult rat brain. Int. J. Neurosci. 119 1303–1318. 10.1080/00207450802333672 [DOI] [PubMed] [Google Scholar]
  88. Das S. C., Yamamoto B. K., Hristov A. M., Sari Y. (2015). Ceftriaxone attenuates ethanol drinking and restores extracellular glutamate concentration through normalization of GLT-1 in nucleus accumbens of male alcohol-preferring rats. Neuropharmacology 97 67–74. 10.1016/j.neuropharm.2015.05.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Dawson D. A., Goldstein R. B., Chou S. P., Ruan W. J., Grant B. F. (2008). Age at first drink and the first incidence of adult-onset DSM-IV alcohol use disorders. Alcohol. Clin. Exp. Res. 32 2149–2160. 10.1111/j.1530-0277.2008.00806.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. De Bock M., Wang N., Bol M., Decrock E., Ponsaerts R., Bultynck G., et al. (2012). Connexin 43 hemichannels contribute to cytoplasmic Ca2+ oscillations by providing a bimodal Ca2+-dependent Ca2+ entry pathway. J. Biol. Chem. 287 12250–12266. 10.1074/jbc.M111.299610 [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. DeFronzo R. A., Jacot E., Jequier E., Maeder E., Wahren J., Felber J. P. (1981). The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30 1000–1007. 10.2337/diab.30.12.1000 [DOI] [PubMed] [Google Scholar]
  92. Delgado R., Carlin A., Airaghi L., Demitri M. T., Meda L., Galimberti D., et al. (1998). Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia. J. Leukoc. Biol. 63 740–745. [DOI] [PubMed] [Google Scholar]
  93. DeWit D. J., Adlaf E. M., Offord D. R., Ogborne A. C. (2000). Age at first alcohol use: a risk factor for the development of alcohol disorders. Am. J. Psychiatry 157 745–750. 10.1176/appi.ajp.157.5.745 [DOI] [PubMed] [Google Scholar]
  94. D’hondt C., Ponsaerts R., De Smedt H., Bultynck G., Himpens B. (2009). Pannexins, distant relatives of the connexin family with specific cellular functions? Bioessays 31 953–974. 10.1002/bies.200800236 [DOI] [PubMed] [Google Scholar]
  95. Dlugos C. A., Pentney R. J. (2001). Quantitative immunocytochemistry of glia in the cerebellar cortex of old ethanol-fed rats. Alcohol 23 63–69. 10.1016/S0741-8329(00)00143-9 [DOI] [PubMed] [Google Scholar]
  96. Donath M. Y., Shoelson S. E. (2011). Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 11 98–107. 10.1038/nri2925 [DOI] [PubMed] [Google Scholar]
  97. Donovan J. E. (2004). Adolescent alcohol initiation: a review of psychosocial risk factors. J. Adolesc. Health 35 529e7–18. [DOI] [PubMed] [Google Scholar]
  98. Douen A. G., Ramlal T., Rastogi S., Bilan P. J., Cartee G. D., Vranic M., et al. (1990). Exercise induces recruitment of the “insulin-responsive glucose transporter”. Evidence for distinct intracellular insulin- and exercise-recruitable transporter pools in skeletal muscle. J. Biol. Chem. 265 13427–13430. [PubMed] [Google Scholar]
  99. Dube D., Lissitzky J. C., Leclerc R., Pelletier G. (1978). Localization of alpha-melanocyte-stimulating hormone in rat brain and pituitary. Endocrinology 102 1283–1291. 10.1210/endo-102-4-1283 [DOI] [PubMed] [Google Scholar]
  100. Edenberg H. J., Foroud T. (2013). Genetics and alcoholism. Nat. Rev. Gastroenterol. Hepatol. 10 487–494. 10.1038/nrgastro.2013.86 [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Ellacott K. L., Cone R. D. (2006). The role of the central melanocortin system in the regulation of food intake and energy homeostasis: lessons from mouse models. Philos. Trans. R. Soc. Lond. B Biol. Sci. 361 1265–1274. 10.1098/rstb.2006.1861 [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Ericson M., Chau P., Clarke R. B., Adermark L., Söderpalm B. (2011). Rising taurine and ethanol concentrations in nucleus accumbens interact to produce dopamine release after ethanol administration. Addict. Biol. 16 377–385. 10.1111/j.1369-1600.2010.00245.x [DOI] [PubMed] [Google Scholar]
  103. Evans T., Mccarthy K. D., Harden T. K. (1984). Regulation of cyclic-amp accumulation by peptide-hormone receptors in immunocytochemically defined astroglial cells. J. Neurochem. 43 131–138. 10.1111/j.1471-4159.1984.tb06688.x [DOI] [PubMed] [Google Scholar]
  104. Everitt B. J., Robbins T. W. (2005). Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat. Neurosci. 8 1481–1489. 10.1038/nn1579 [DOI] [PubMed] [Google Scholar]
  105. Evrard S. G., Duhalde-Vega M., Tagliaferro P., Mirochnic S., Caltana L. R., Brusco A. (2006). A low chronic ethanol exposure induces morphological changes in the adolescent rat brain that are not fully recovered even after a long abstinence: an immunohistochemical study. Exp. Neurol. 200 438–459. 10.1016/j.expneurol.2006.03.001 [DOI] [PubMed] [Google Scholar]
  106. Fan W., Boston B. A., Kesterson R. A., Hruby V. J., Cone R. D. (1997). Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385 165–168. 10.1038/385165a0 [DOI] [PubMed] [Google Scholar]
  107. Farooqi I. S., Keogh J. M., Yeo G. S., Lank E. J., Cheetham T., O’rahilly S. (2003). Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N. Engl. J. Med. 348 1085–1095. 10.1056/NEJMoa022050 [DOI] [PubMed] [Google Scholar]
  108. Fernandez-Fernandez S., Almeida A., Bolanos J. P. (2012). Antioxidant and bioenergetic coupling between neurons and astrocytes. Biochem. J. 443 3–11. 10.1042/BJ20111943 [DOI] [PubMed] [Google Scholar]
  109. Fernandez-Lizarbe S., Montesinos J., Guerri C. (2013). Ethanol induces TLR4/TLR2 association, triggering an inflammatory response in microglial cells. J. Neurochem. 126 261–273. 10.1111/jnc.12276 [DOI] [PubMed] [Google Scholar]
  110. Fernandez-Lizarbe S., Pascual M., Guerri C. (2009). Critical role of TLR4 response in the activation of microglia induced by ethanol. J. Immunol. 183 4733–4744. 10.4049/jimmunol.0803590 [DOI] [PubMed] [Google Scholar]
  111. Festa A., D’Agostino R, Jr, Howard G., Mykkänen L., Tracy R. P., Haffner S. M. (2000). Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102 42–47. 10.1161/01.CIR.102.1.42 [DOI] [PubMed] [Google Scholar]
  112. Foley K., Boguslavsky S., Klip A. (2011). Endocytosis, recycling, and regulated exocytosis of glucose transporter 4. Biochemistry 50 3048–3061. 10.1021/bi2000356 [DOI] [PubMed] [Google Scholar]
  113. Gajardo-Gómez R., Labra V. C., Maturana C. J., Shoji K. F., Santibanez C. A., Saez J. C., et al. (2017). Cannabinoids prevent the amyloid beta-induced activation of astroglial hemichannels: a neuroprotective mechanism. Glia 65 122–137. 10.1002/glia.23080 [DOI] [PubMed] [Google Scholar]
  114. Gajardo-Gómez R., Labra V. C., Orellana J. A. (2016). Connexins and pannexins: new insights into microglial functions and dysfunctions. Front. Mol. Neurosci. 9:86 10.3389/fnmol.2016.00086 [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Galimberti D., Baron P., Meda L., Prat E., Scarpini E., Delgado R., et al. (1999). alpha-MSH peptides inhibit production of nitric oxide and tumor necrosis factor-alpha by microglial cells activated with beta-amyloid and interferon gamma. Biochem. Biophys. Res. Commun. 263 251–256. 10.1006/bbrc.1999.1276 [DOI] [PubMed] [Google Scholar]
  116. Garré J. M., Retamal M. A., Cassina P., Barbeito L., Bukauskas F. F., Saez J. C., et al. (2010). FGF-1 induces ATP release from spinal astrocytes in culture and opens pannexin and connexin hemichannels. Proc. Natl. Acad. Sci. U.S.A. 107 22659–22664. 10.1073/pnas.1013793107 [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Garré J. M., Yang G., Bukauskas F. F., Bennett M. V. (2016). FGF-1 Triggers Pannexin-1 hemichannel opening in spinal astrocytes of rodents and promotes inflammatory responses in acute spinal cord slices. J. Neurosci. 36 4785–4801. 10.1523/JNEUROSCI.4195-15.2016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Gavini C. K., Jones W. C., II, Novak C. M. (2016). Ventromedial hypothalamic melanocortin receptor activation: regulation of activity energy expenditure and skeletal muscle thermogenesis. J. Physiol. 594 5285–5301. 10.1113/JP272352 [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Ginhoux F., Greter M., Leboeuf M., Nandi S., See P., Gokhan S., et al. (2010). Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330 841–845. 10.1126/science.1194637 [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Giuliani D., Bitto A., Galantucci M., Zaffe D., Ottani A., Irrera N., et al. (2014). Melanocortins protect against progression of Alzheimer’s disease in triple-transgenic mice by targeting multiple pathophysiological pathways. Neurobiol. Aging 35 537–547. 10.1016/j.neurobiolaging.2013.08.030 [DOI] [PubMed] [Google Scholar]
  121. Giuliani D., Mioni C., Altavilla D., Leone S., Bazzani C., Minutoli L., et al. (2006). Both early and delayed treatment with melanocortin 4 receptor-stimulating melanocortins produces neuroprotection in cerebral ischemia. Endocrinology 147 1126–1135. 10.1210/en.2005-0692 [DOI] [PubMed] [Google Scholar]
  122. Giuliani D., Ottani A., Neri L., Zaffe D., Grieco P., Jochem J., et al. (2017). Multiple beneficial effects of melanocortin MC4 receptor agonists in experimental neurodegenerative disorders: therapeutic perspectives. Prog. Neurobiol. 148 40–56. 10.1016/j.pneurobio.2016.11.004 [DOI] [PubMed] [Google Scholar]
  123. Givens B., McMahon K. (1995). Ethanol suppresses the induction of long-term potentiation in vivo. Brain Res. 688 27–33. 10.1016/0006-8993(95)00499-G [DOI] [PubMed] [Google Scholar]
  124. Gonzalez A., Pariente J. A., Salido G. M. (2007). Ethanol stimulates ROS generation by mitochondria through Ca2+ mobilization and increases GFAP content in rat hippocampal astrocytes. Brain Res. 1178 28–37. 10.1016/j.brainres.2007.08.040 [DOI] [PubMed] [Google Scholar]
  125. Gonzalez-Reimers E., Fernandez-Rodriguez C. M., Santolaria-Fernandez F., De La Vega-Prieto M. J., Martin-Gonzalez C., Gomez-Rodriguez M. A., et al. (2011). Interleukin-15 and other myokines in chronic alcoholics. Alcohol Alcohol. 46 529–533. 10.1093/alcalc/agr064 [DOI] [PubMed] [Google Scholar]
  126. Gore F. M., Bloem P. J., Patton G. C., Ferguson J., Joseph V., Coffey C., et al. (2011). Global burden of disease in young people aged 10-24 years: a systematic analysis. Lancet 377 2093–2102. 10.1016/S0140-6736(11)60512-6 [DOI] [PubMed] [Google Scholar]
  127. Gourley S. L., Taylor J. R. (2016). Going and stopping: dichotomies in behavioral control by the prefrontal cortex. Nat. Neurosci. 19 656–664. 10.1038/nn.4275 [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Gropp E., Shanabrough M., Borok E., Xu A. W., Janoschek R., Buch T., et al. (2005). Agouti-related peptide-expressing neurons are mandatory for feeding. Nat. Neurosci. 8 1289–1291. 10.1038/nn1548 [DOI] [PubMed] [Google Scholar]
  129. Guasch R. M., Blanco A. M., Perez-Arago A., Minambres R., Talens-Visconti R., Peris B., et al. (2007). RhoE participates in the stimulation of the inflammatory response induced by ethanol in astrocytes. Exp. Cell Res. 313 3779–3788. 10.1016/j.yexcr.2007.07.018 [DOI] [PubMed] [Google Scholar]
  130. Hadley M. E., Haskell-Luevano C. (1999). The proopiomelanocortin system. Ann. N. Y. Acad. Sci. 885 1–21. 10.1111/j.1749-6632.1999.tb08662.x [DOI] [PubMed] [Google Scholar]
  131. Hanisch U. K. (2002). Microglia as a source and target of cytokines. Glia 40 140–155. 10.1002/glia.10161 [DOI] [PubMed] [Google Scholar]
  132. Harrold J. A., Williams G. (2006). Melanocortin-4 receptors, beta-MSH and leptin: key elements in the satiety pathway. Peptides 27 365–371. 10.1016/j.peptides.2005.01.030 [DOI] [PubMed] [Google Scholar]
  133. Haskell-Luevano C., Monck E. K. (2001). Agouti-related protein functions as an inverse agonist at a constitutively active brain melanocortin-4 receptor. Regul. Pept. 99 1–7. 10.1016/S0167-0115(01)00234-8 [DOI] [PubMed] [Google Scholar]
  134. He J., Crews F. T. (2008). Increased MCP-1 and microglia in various regions of the human alcoholic brain. Exp. Neurol. 210 349–358. 10.1016/j.expneurol.2007.11.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Heaton M. B., Paiva M., Madorsky I., Shaw G. (2003). Ethanol effects on neonatal rat cortex: comparative analyses of neurotrophic factors, apoptosis-related proteins, and oxidative processes during vulnerable and resistant periods. Brain Res. Dev. Brain Res. 145 249–262. 10.1016/j.devbrainres.2003.08.005 [DOI] [PubMed] [Google Scholar]
  136. Holloszy J. O. (2005). Exercise-induced increase in muscle insulin sensitivity. J. Appl. Physiol. 99 338–343. 10.1152/japplphysiol.00123.2005 [DOI] [PubMed] [Google Scholar]
  137. Huang Q. H., Tatro J. B. (2002). alpha-melanocyte stimulating hormone suppresses intracerebral tumor necrosis factor-alpha and interleukin-1 beta gene expression following transient cerebral ischemia in mice. Neurosci. Lett. 334 186–190. 10.1016/S0304-3940(02)01088-1 [DOI] [PubMed] [Google Scholar]
  138. Huszar D., Lynch C. A., Fairchild-Huntress V., Dunmore J. H., Fang Q., Berkemeier L. R., et al. (1997). Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88 131–141. 10.1016/S0092-8674(00)81865-6 [DOI] [PubMed] [Google Scholar]
  139. Ida T., Hara M., Nakamura Y., Kozaki S., Tsunoda S., Ihara H. (2008). Cytokine-induced enhancement of calcium-dependent glutamate release from astrocytes mediated by nitric oxide. Neurosci. Lett. 432 232–236. 10.1016/j.neulet.2007.12.047 [DOI] [PubMed] [Google Scholar]
  140. Iglesias R., Dahl G., Qiu F., Spray D. C., Scemes E. (2009). Pannexin 1: the molecular substrate of astrocyte “hemichannels”. J. Neurosci. 29 7092–7097. 10.1523/JNEUROSCI.6062-08.2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Jacobowitz D. M., O’Donohue T. L. (1978). Alpha-melanocyte stimulating hormone - immunohistochemical identification and mapping in neurons of rat-brain. Proc. Natl. Acad. Sci. U.S.A. 75 6300–6304. 10.1073/pnas.75.12.6300 [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. Kane C. J., Phelan K. D., Douglas J. C., Wagoner G., Johnson J. W., Xu J., et al. (2014). Effects of ethanol on immune response in the brain: region-specific changes in adolescent versus adult mice. Alcohol. Clin. Exp. Res. 38 384–391. 10.1111/acer.12244 [DOI] [PMC free article] [PubMed] [Google Scholar]
  143. Kanneganti T. D., Lamkanfi M., Kim Y. G., Chen G., Park J. H., Franchi L., et al. (2007). Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling. Immunity 26 433–443. 10.1016/j.immuni.2007.03.008 [DOI] [PubMed] [Google Scholar]
  144. Kettenmann H., Hanisch U. K., Noda M., Verkhratsky A. (2011). Physiology of microglia. Physiol. Rev. 91 461–553. 10.1152/physrev.00011.2010 [DOI] [PubMed] [Google Scholar]
  145. Kimelberg H. K., Cheema M., O’connor E. R., Tong H., Goderie S. K., Rossman P. A. (1993). Ethanol-induced aspartate and taurine release from primary astrocyte cultures. J. Neurochem. 60 1682–1689. 10.1111/j.1471-4159.1993.tb13391.x [DOI] [PubMed] [Google Scholar]
  146. Kirby T., Barry A. E. (2012). Alcohol as a gateway drug: a study of US 12th graders. J. Sch. Health 82 371–379. 10.1111/j.1746-1561.2012.00712.x [DOI] [PubMed] [Google Scholar]
  147. Kishi T., Aschkenasi C. J., Lee C. E., Mountjoy K. G., Saper C. B., Elmquist J. K. (2003). Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat. J. Comp. Neurol. 457 213–235. 10.1002/cne.10454 [DOI] [PubMed] [Google Scholar]
  148. Kokare D. M., Singru P. S., Dandekar M. P., Chopde C. T., Subhedar N. K. (2008). Involvement of alpha-melanocyte stimulating hormone (alpha-MSH) in differential ethanol exposure and withdrawal related depression in rat: neuroanatomical-behavioral correlates. Brain Res. 1216 53–67. 10.1016/j.brainres.2008.03.064 [DOI] [PubMed] [Google Scholar]
  149. Koob G. F. (2013). Negative reinforcement in drug addiction: the darkness within. Curr. Opin. Neurobiol. 23 559–563. 10.1016/j.conb.2013.03.011 [DOI] [PubMed] [Google Scholar]
  150. Koob G. F., Le Moal M. (2005). Plasticity of reward neurocircuitry and the ’dark side’ of drug addiction. Nat. Neurosci. 8 1442–1444. 10.1038/nn1105-1442 [DOI] [PubMed] [Google Scholar]
  151. Korbo L. (1999). Glial cell loss in the hippocampus of alcoholics. Alcohol. Clin. Exp. Res. 23 164–168. 10.1111/j.1530-0277.1999.tb04039.x [DOI] [PubMed] [Google Scholar]
  152. Korkotian E., Botalova A., Odegova T., Segal M. (2015). Chronic exposure to alcohol alters network activity and morphology of cultured hippocampal neurons. Neurotoxicology 47 62–71. 10.1016/j.neuro.2015.01.005 [DOI] [PubMed] [Google Scholar]
  153. Krystal J. H., Petrakis I. L., Mason G., Trevisan L., D’souza D. C. (2003). N-methyl-D-aspartate glutamate receptors and alcoholism: reward, dependence, treatment, and vulnerability. Pharmacol. Ther. 99 79–94. 10.1016/S0163-7258(03)00054-8 [DOI] [PubMed] [Google Scholar]
  154. Kuppers E., Gleiser C., Brito V., Wachter B., Pauly T., Hirt B., et al. (2008). AQP4 expression in striatal primary cultures is regulated by dopamine - implications for proliferation of astrocytes. Eur. J. Neurosci. 28 2173–2182. 10.1111/j.1460-9568.2008.06531.x [DOI] [PubMed] [Google Scholar]
  155. Kyzar E. J., Pandey S. C. (2015). Molecular mechanisms of synaptic remodeling in alcoholism. Neurosci. Lett. 601 11–19. 10.1016/j.neulet.2015.01.051 [DOI] [PMC free article] [PubMed] [Google Scholar]
  156. Lam T. K., Schwartz G. J., Rossetti L. (2005). Hypothalamic sensing of fatty acids. Nat. Neurosci. 8 579–584. 10.1038/nn1456 [DOI] [PubMed] [Google Scholar]
  157. Lang C. H., Derdak Z., Wands J. R. (2014). Strain-dependent differences for suppression of insulin-stimulated glucose uptake in skeletal and cardiac muscle by ethanol. Alcohol. Clin. Exp. Res. 38 897–910. 10.1111/acer.12343 [DOI] [PMC free article] [PubMed] [Google Scholar]
  158. Lau A., Tymianski M. (2010). Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers. Arch. 460 525–542. 10.1007/s00424-010-0809-1 [DOI] [PubMed] [Google Scholar]
  159. Lawson L. J., Perry V. H., Dri P., Gordon S. (1990). Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39 151–170. 10.1016/0306-4522(90)90229-W [DOI] [PubMed] [Google Scholar]
  160. Lee A. D., Hansen P. A., Holloszy J. O. (1995). Wortmannin inhibits insulin-stimulated but not contraction-stimulated glucose transport activity in skeletal muscle. FEBS Lett. 361 51–54. 10.1016/0014-5793(95)00147-2 [DOI] [PubMed] [Google Scholar]
  161. Lee M. R., Ruby C. L., Hinton D. J., Choi S., Adams C. A., Young Kang N., et al. (2013). Striatal adenosine signaling regulates EAAT2 and astrocytic AQP4 expression and alcohol drinking in mice. Neuropsychopharmacology 38 437–445. 10.1038/npp.2012.198 [DOI] [PMC free article] [PubMed] [Google Scholar]
  162. Lerma-Cabrera J. M., Carvajal F., Alcaraz-Iborra M., De La Fuente L., Navarro M., Thiele T. E., et al. (2013a). Adolescent binge-like ethanol exposure reduces basal alpha-MSH expression in the hypothalamus and the amygdala of adult rats. Pharmacol. Biochem. Behav. 110 66–74. 10.1016/j.pbb.2013.06.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  163. Lerma-Cabrera J. M., Carvajal F., Chotro G., Gaztanaga M., Navarro M., Thiele T. E., et al. (2013b). MC4-R signaling within the nucleus accumbens shell, but not the lateral hypothalamus, modulates ethanol palatability in rats. Behav. Brain Res. 239 51–54. 10.1016/j.bbr.2012.10.055 [DOI] [PMC free article] [PubMed] [Google Scholar]
  164. Lerma-Cabrera J. M., Carvajal F., De La Torre L., De La Fuente L., Navarro M., Thiele T. E., et al. (2012). Control of food intake by MC4-R signaling in the lateral hypothalamus, nucleus accumbens shell and ventral tegmental area: interactions with ethanol. Behav. Brain Res. 234 51–60. 10.1016/j.bbr.2012.06.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  165. Lin H. V., Plum L., Ono H., Gutierrez-Juarez R., Shanabrough M., Borok E., et al. (2010). Divergent regulation of energy expenditure and hepatic glucose production by insulin receptor in agouti-related protein and POMC neurons. Diabetes Metab. Res. Rev 59 337–346. 10.2337/db09-1303 [DOI] [PMC free article] [PubMed] [Google Scholar]
  166. Lindberg C., Hjorth E., Post C., Winblad B., Schultzberg M. (2005). Cytokine production by a human microglial cell line: effects of β-amyloid and α-melanocyte-stimulating hormone. Neurotox. Res. 8 267–276. 10.1007/BF03033980 [DOI] [PubMed] [Google Scholar]
  167. Lindblom J., Wikberg J. E., Bergstrom L. (2002). Alcohol-preferring AA rats show a derangement in their central melanocortin signalling system. Pharmacol. Biochem. Behav. 72 491–496. 10.1016/S0091-3057(02)00719-0 [DOI] [PubMed] [Google Scholar]
  168. Lippai D., Bala S., Csak T., Kurt-Jones E. A., Szabo G. (2013a). Chronic alcohol-induced microRNA-155 contributes to neuroinflammation in a TLR4-dependent manner in mice. PLoS ONE 8:e70945 10.1371/journal.pone.0070945 [DOI] [PMC free article] [PubMed] [Google Scholar]
  169. Lippai D., Bala S., Petrasek J., Csak T., Levin I., Kurt-Jones E. A., et al. (2013b). Alcohol-induced IL-1beta in the brain is mediated by NLRP3/ASC inflammasome activation that amplifies neuroinflammation. J. Leukoc. Biol. 94 171–182. 10.1189/jlb.1212659 [DOI] [PMC free article] [PubMed] [Google Scholar]
  170. Lipton J. M., Zhao H., Ichiyama T., Barsh G. S., Catania A. (1999). Mechanisms of antiinflammatory action of alpha-MSH peptides. In vivo and in vitro evidence. Ann. N. Y. Acad. Sci. 885 173–182. 10.1111/j.1749-6632.1999.tb08674.x [DOI] [PubMed] [Google Scholar]
  171. Liu D., Zhang H. G., Zhao Z. A., Chang M. T., Li Y., Yu J., et al. (2015). Melanocortin MC4 receptor agonists alleviate brain damage in abdominal compartment syndrome in the rat. Neuropeptides 49 55–61. 10.1016/j.npep.2014.12.003 [DOI] [PubMed] [Google Scholar]
  172. Liu H., Kishi T., Roseberry A. G., Cai X., Lee C. E., Montez J. M., et al. (2003). Transgenic mice expressing green fluorescent protein under the control of the melanocortin-4 receptor promoter. J. Neurosci. 23 7143–7154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  173. Locovei S., Scemes E., Qiu F., Spray D. C., Dahl G. (2007). Pannexin1 is part of the pore forming unit of the P2X(7) receptor death complex. FEBS Lett. 581 483–488. 10.1016/j.febslet.2006.12.056 [DOI] [PMC free article] [PubMed] [Google Scholar]
  174. Locovei S., Wang J., Dahl G. (2006). Activation of pannexin 1 channels by ATP through P2Y receptors and by cytoplasmic calcium. FEBS Lett. 580 239–244. 10.1016/j.febslet.2005.12.004 [DOI] [PubMed] [Google Scholar]
  175. Lovinger D. M., White G., Weight F. F. (1989). Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science 243 1721–1724. 10.1126/science.2467382 [DOI] [PubMed] [Google Scholar]
  176. Luquet S., Perez F. A., Hnasko T. S., Palmiter R. D. (2005). NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. Science 310 683–685. 10.1126/science.1115524 [DOI] [PubMed] [Google Scholar]
  177. Maldonado-Devincci A. M., Badanich K. A., Kirstein C. L. (2010). Alcohol during adolescence selectively alters immediate and long-term behavior and neurochemistry. Alcohol 44 57–66. 10.1016/j.alcohol.2009.09.035 [DOI] [PMC free article] [PubMed] [Google Scholar]
  178. Matsumoto H., Matsumoto I. (2008). Alcoholism: protein expression profiles in a human hippocampal model. Expert Rev. Proteomics 5 321–331. 10.1586/14789450.5.2.321 [DOI] [PubMed] [Google Scholar]
  179. Mayfield J., Ferguson L., Harris R. A. (2013). Neuroimmune signaling: a key component of alcohol abuse. Curr. Opin. Neurobiol. 23 513–520. 10.1016/j.conb.2013.01.024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  180. McBride O., Cheng H. G. (2011). Exploring the emergence of alcohol use disorder symptoms in the two years after onset of drinking: findings from the National Surveys on Drug Use and Health. Addiction 106 555–563. 10.1111/j.1360-0443.2010.03242.x [DOI] [PubMed] [Google Scholar]
  181. McCarthy A. M., Elmendorf J. S. (2007). GLUT4’s itinerary in health & disease. Indian J. Med. Res. 125 373–388. [PubMed] [Google Scholar]
  182. McClain J. A., Morris S. A., Deeny M. A., Marshall S. A., Hayes D. M., Kiser Z. M., et al. (2011). Adolescent binge alcohol exposure induces long-lasting partial activation of microglia. Brain Behav. Immun. 25 S120–S128. 10.1016/j.bbi.2011.01.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  183. Melia K. R., Ryabinin A. E., Corodimas K. P., Wilson M. C., Ledoux J. E. (1996). Hippocampal-dependent learning and experience-dependent activation of the hippocampus are preferentially disrupted by ethanol. Neuroscience 74 313–322. 10.1016/0306-4522(96)00138-8 [DOI] [PubMed] [Google Scholar]
  184. Miguel-Hidalgo J. J., Overholser J. C., Meltzer H. Y., Stockmeier C. A., Rajkowska G. (2006). Reduced glial and neuronal packing density in the orbitofrontal cortex in alcohol dependence and its relationship with suicide and duration of alcohol dependence. Alcohol. Clin. Exp. Res. 30 1845–1855. 10.1111/j.1530-0277.2006.00221.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  185. Miguel-Hidalgo J. J., Wei J. R., Andrew M., Overholser J. C., Jurjus G., Stockmeier C. A., et al. (2002). Glia pathology in the prefrontal cortex in alcohol dependence with and without depressive symptoms. Biol. Psychiatry 52 1121–1133. 10.1016/S0006-3223(02)01439-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  186. Minkiewicz J., De Rivero Vaccari J. P., Keane R. W. (2013). Human astrocytes express a novel NLRP2 inflammasome. Glia 61 1113–1121. 10.1002/glia.22499 [DOI] [PubMed] [Google Scholar]
  187. Mokdad A. H., Forouzanfar M. H., Daoud F., Mokdad A. A., Bcheraoui El C., Moradi-Lakeh M., et al. (2016). Global burden of diseases, injuries, and risk factors for young people’s health during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 387 2383–2401. 10.1016/S0140-6736(16)00648-6 [DOI] [PubMed] [Google Scholar]
  188. Molander A., Lof E., Stomberg R., Ericson M., Soderpalm B. (2005). Involvement of accumbal glycine receptors in the regulation of voluntary ethanol intake in the rat. Alcohol. Clin. Exp. Res. 29 38–45. 10.1097/01.ALC.0000150009.78622.E0 [DOI] [PubMed] [Google Scholar]
  189. Molina P. E., Lang C. H., Bagby G. J., Spitzer J. J. (1991). Ethanol oxidation is not required to attenuate endotoxin-enhanced glucose metabolism. Am. J. Physiol. 260 R1058–R1065. [DOI] [PubMed] [Google Scholar]
  190. Montero T. D., Orellana J. A. (2015). Hemichannels: new pathways for gliotransmitter release. Neuroscience 286 45–59. 10.1016/j.neuroscience.2014.11.048 [DOI] [PubMed] [Google Scholar]
  191. Montoliu C., Sancho-Tello M., Azorin I., Burgal M., Valles S., Renau-Piqueras J., et al. (1995). Ethanol increases cytochrome P4502E1 and induces oxidative stress in astrocytes. J. Neurochem. 65 2561–2570. 10.1046/j.1471-4159.1995.65062561.x [DOI] [PubMed] [Google Scholar]
  192. Moran T. H. (2004). Gut peptides in the control of food intake: 30 years of ideas. Physiol. Behav. 82 175–180. 10.1016/j.physbeh.2004.04.048 [DOI] [PubMed] [Google Scholar]
  193. Moran T. H. (2006). Gut peptide signaling in the controls of food intake. Obesity (Silver Spring) 14 250S–253S. 10.1038/oby.2006.318 [DOI] [PubMed] [Google Scholar]
  194. Mountjoy K. G. (2010a). Distribution and function of melanocortin receptors within the brain. Adv. Exp. Med. Biol. 681 29–48. 10.1007/978-1-4419-6354-3_3 [DOI] [PubMed] [Google Scholar]
  195. Mountjoy K. G. (2010b). Functions for pro-opiomelanocortin-derived peptides in obesity and diabetes. Biochem. J. 428 305–324. 10.1042/BJ20091957 [DOI] [PubMed] [Google Scholar]
  196. Muceniece R., Zvejniece L., Kirjanova O., Liepinsh E., Krigere L., Baumane L., et al. (2004). beta- and gamma-melanocortins inhibit lipopolysaccharide induced nitric oxide production in mice brain. Brain Res. 995 7–13. 10.1016/j.brainres.2003.09.039 [DOI] [PubMed] [Google Scholar]
  197. Murphy N., Cowley T. R., Richardson J. C., Virley D., Upton N., Walter D., et al. (2012). The neuroprotective effect of a specific P2X(7) receptor antagonist derives from its ability to inhibit assembly of the NLRP3 inflammasome in glial cells. Brain Pathol. 22 295–306. 10.1111/j.1750-3639.2011.00531.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  198. Muscoli C., Fresta M., Cardile V., Palumbo M., Renis M., Puglisi G., et al. (2002). Ethanol-induced injury in rat primary cortical astrocytes involves oxidative stress: effect of idebenone. Neurosci. Lett. 329 21–24. 10.1016/S0304-3940(02)00567-0 [DOI] [PubMed] [Google Scholar]
  199. Mykicki N., Herrmann A. M., Schwab N., Deenen R., Sparwasser T., Limmer A., et al. (2016). Melanocortin-1 receptor activation is neuroprotective in mouse models of neuroinflammatory disease. Sci. Transl. Med. 8 362ra146 10.1126/scitranslmed.aaf8732 [DOI] [PubMed] [Google Scholar]
  200. Nam H. W., Mciver S. R., Hinton D. J., Thakkar M. M., Sari Y., Parkinson F. E., et al. (2012). Adenosine and glutamate signaling in neuron-glial interactions: implications in alcoholism and sleep disorders. Alcohol. Clin. Exp. Res. 36 1117–1125. 10.1111/j.1530-0277.2011.01722.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  201. Narasimhan M., Rathinam M., Patel D., Henderson G., Mahimainathan L. (2012). Astrocytes prevent ethanol induced apoptosis of Nrf2 depleted neurons by maintaining GSH homeostasis. Open J. Apoptosis 1 10.4236/ojapo.2012.12002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  202. Nargund R. P., Strack A. M., Fong T. M. (2006). Melanocortin-4 receptor (MC4R) agonists for the treatment of obesity. J. Med. Chem. 49 4035–4043. 10.1021/jm058241a [DOI] [PubMed] [Google Scholar]
  203. Navarro M., Cubero I., Knapp D. J., Breese G. R., Thiele T. E. (2008). Decreased immunoreactivity of the melanocortin neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) after chronic ethanol exposure in Sprague-Dawley rats. Alcohol. Clin. Exp. Res. 32 266–276. 10.1111/j.1530-0277.2007.00578.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  204. Navarro M., Cubero I., Knapp D. J., Thiele T. E. (2003). MTII-induced reduction of voluntary ethanol drinking is blocked by pretreatment with AgRP-(83-132). Neuropeptides 37 338–344. 10.1016/j.npep.2003.10.003 [DOI] [PubMed] [Google Scholar]
  205. Navarro M., Cubero I., Thiele T. E. (2013). Decreased immunoreactivity of the polypeptide precursor pro-opiomelanocortin (POMC) and the prohormone convertase pc1/3 after chronic ethanol exposure in Sprague-Dawley rats. Alcohol. Clin. Exp. Res. 37 399–406. 10.1111/j.1530-0277.2012.01951.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  206. Navarro M., Lerma-Cabrera J. M., Carvajal F., Lowery E. G., Cubero I., Thiele T. E. (2011). Assessment of voluntary ethanol consumption and the effects of a melanocortin (MC) receptor agonist on ethanol intake in mutant C57BL/6J mice lacking the MC-4 receptor. Alcohol. Clin. Exp. Res. 35 1058–1066. 10.1111/j.1530-0277.2011.01438.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  207. Nennig S. E., Schank J. R. (2017). The role of NFkB in drug addiction: beyond inflammation. Alcohol Alcohol. 52 172–179. 10.1093/alcalc/agw098 [DOI] [PMC free article] [PubMed] [Google Scholar]
  208. NIAAA Newstetter (2004). National Institute of Alcohol Abuse and Alcoholism. Bethesda: Department of health and human Services-National Institutes of Health website. Office of Research Translation and Communications. Available at: http://pubs.niaaa.nih.gov/publications/Newsletter/winter2004/Newsletter [Google Scholar]
  209. Nijenhuis W. A., Oosterom J., Adan R. A. (2001). AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor. Mol. Endocrinol. 15 164–171. [DOI] [PubMed] [Google Scholar]
  210. Nixon K., Kim D. H., Potts E. N., He J., Crews F. T. (2008). Distinct cell proliferation events during abstinence after alcohol dependence: microglia proliferation precedes neurogenesis. Neurobiol. Dis. 31 218–229. 10.1016/j.nbd.2008.04.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  211. Nogueiras R., Wiedmer P., Perez-Tilve D., Veyrat-Durebex C., Keogh J. M., Sutton G. M., et al. (2007). The central melanocortin system directly controls peripheral lipid metabolism. J. Clin. Invest. 117 3475–3488. 10.1172/JCI31743 [DOI] [PMC free article] [PubMed] [Google Scholar]
  212. Obici S., Feng Z., Tan J., Liu L., Karkanias G., Rossetti L. (2001). Central melanocortin receptors regulate insulin action. J. Clin. Invest. 108 1079–1085. 10.1172/JCI200112954 [DOI] [PMC free article] [PubMed] [Google Scholar]
  213. O’Donohue T. L., Jacobowitz D. M. (1980). Studies of alpha-MSH-containing nerves in the brain. Prog. Biochem. Pharmacol. 16 69–83. [PubMed] [Google Scholar]
  214. O’Donohue T. L., Miller R. L., Jacobowitz D. M. (1979). Identification, characterization and stereotaxic mapping of intraneuronal alpha-melanocyte stimulating hormone-like immunoreactive peptides in discrete regions of the rat brain. Brain Res. 176 101–123. 10.1016/0006-8993(79)90873-4 [DOI] [PubMed] [Google Scholar]
  215. Oliveira A. C., Pereira M. C., Santana L. N. D. S., Fernandes R. M., Teixeira F. B., Oliveira G. B., et al. (2015). Chronic ethanol exposure during adolescence through early adulthood in female rats induces emotional and memory deficits associated with morphological and molecular alterations in hippocampus. J. Psychopharmacol. 29 712–724. 10.1177/0269881115581960 [DOI] [PubMed] [Google Scholar]
  216. Olney J. J., Navarro M., Thiele T. E. (2014). Targeting central melanocortin receptors: a promising novel approach for treating alcohol abuse disorders. Front. Neurosci. 8:128 10.3389/fnins.2014.00128 [DOI] [PMC free article] [PubMed] [Google Scholar]
  217. Orellana J. A., Avendano B. C., Montero T. D. (2014a). Role of connexins and pannexins in ischemic stroke. Curr. Med. Chem. 21 2165–2182. [DOI] [PubMed] [Google Scholar]
  218. Orellana J. A., Busso D., Ramirez G., Campos M., Rigotti A., Eugenin J., et al. (2014b). Prenatal nicotine exposure enhances Cx43 and Panx1 unopposed channel activity in brain cells of adult offspring mice fed a high-fat/cholesterol diet. Front. Cell Neurosci. 8:403 10.3389/fncel.2014.00403 [DOI] [PMC free article] [PubMed] [Google Scholar]
  219. Orellana J. A., Froger N., Ezan P., Jiang J. X., Bennett M. V., Naus C. C., et al. (2011a). ATP and glutamate released via astroglial connexin 43 hemichannels mediate neuronal death through activation of pannexin 1 hemichannels. J. Neurochem. 118 826–840. 10.1111/j.1471-4159.2011.07210.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  220. Orellana J. A., Shoji K. F., Abudara V., Ezan P., Amigou E., Saez P. J., et al. (2011b). Amyloid beta-induced death in neurons involves glial and neuronal hemichannels. J. Neurosci. 31 4962–4977. 10.1523/JNEUROSCI.6417-10.2011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  221. Orellana J. A., Montero T. D., Von Bernhardi R. (2013). Astrocytes inhibit nitric oxide-dependent Ca(2+) dynamics in activated microglia: involvement of ATP released via pannexin 1 channels. Glia 61 2023–2037. 10.1002/glia.22573 [DOI] [PubMed] [Google Scholar]
  222. Orellana J. A., Moraga-Amaro R., Diaz-Galarce R., Rojas S., Maturana C. J., Stehberg J., et al. (2015). Restraint stress increases hemichannel activity in hippocampal glial cells and neurons. Front. Cell Neurosci. 9:102 10.3389/fncel.2015.00102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  223. Orellana J. A., Retamal M. A., Moraga-Amaro R., Stehberg J. (2016). Role of astroglial hemichannels and pannexons in memory and neurodegenerative diseases. Front. Integr. Neurosci. 10:26 10.3389/fnint.2016.00026 [DOI] [PMC free article] [PubMed] [Google Scholar]
  224. Ortiz J., Fitzgerald L. W., Charlton M., Lane S., Trevisan L., Guitart X., et al. (1995). Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine system. Synapse 21 289–298. 10.1002/syn.890210403 [DOI] [PubMed] [Google Scholar]
  225. Pascual M., Boix J., Felipo V., Guerri C. (2009). Repeated alcohol administration during adolescence causes changes in the mesolimbic dopaminergic and glutamatergic systems and promotes alcohol intake in the adult rat. J. Neurochem. 108 920–931. 10.1111/j.1471-4159.2008.05835.x [DOI] [PubMed] [Google Scholar]
  226. Pekny M., Nilsson M. (2005). Astrocyte activation and reactive gliosis. Glia 50 427–434. 10.1002/glia.20207 [DOI] [PubMed] [Google Scholar]
  227. Pelegrin P., Surprenant A. (2006). Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO J. 25 5071–5082. 10.1038/sj.emboj.7601378 [DOI] [PMC free article] [PubMed] [Google Scholar]
  228. Perea G., Navarrete M., Araque A. (2009). Tripartite synapses: astrocytes process and control synaptic information. Trends Neurosci. 32 421–431. 10.1016/j.tins.2009.05.001 [DOI] [PubMed] [Google Scholar]
  229. Pereira L. O., Lancha A. H., Jr. (2004). Effect of insulin and contraction up on glucose transport in skeletal muscle. Prog. Biophys. Mol. Biol. 84 1–27. 10.1016/S0079-6107(03)00055-5 [DOI] [PubMed] [Google Scholar]
  230. Ploj K., Roman E., Kask A., Hyytia P., Schioth H. B., Wikberg J. E., et al. (2002). Effects of melanocortin receptor ligands on ethanol intake and opioid peptide levels in alcohol-preferring AA rats. Brain Res. Bull. 59 97–104. 10.1016/S0361-9230(02)00844-4 [DOI] [PubMed] [Google Scholar]
  231. Plum L., Belgardt B. F., Bruning J. C. (2006). Central insulin action in energy and glucose homeostasis. J. Clin. Invest. 116 1761–1766. 10.1172/JCI29063 [DOI] [PMC free article] [PubMed] [Google Scholar]
  232. Prochnow N., Abdulazim A., Kurtenbach S., Wildforster V., Dvoriantchikova G., Hanske J., et al. (2012). Pannexin1 stabilizes synaptic plasticity and is needed for learning. PLoS ONE 7:e51767 10.1371/journal.pone.0051767 [DOI] [PMC free article] [PubMed] [Google Scholar]
  233. Qin L., Crews F. T. (2012a). Chronic ethanol increases systemic TLR3 agonist-induced neuroinflammation and neurodegeneration. J. Neuroinflammation 9:130 10.1186/1742-2094-9-130 [DOI] [PMC free article] [PubMed] [Google Scholar]
  234. Qin L., Crews F. T. (2012b). NADPH oxidase and reactive oxygen species contribute to alcohol-induced microglial activation and neurodegeneration. J. Neuroinflammation 9:5 10.1186/1742-2094-9-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  235. Rada P., Avena N. M., Leibowitz S. F., Hoebel B. G. (2004). Ethanol intake is increased by injection of galanin in the paraventricular nucleus and reduced by a galanin antagonist. Alcohol 33 91–97. 10.1016/S0741-8329(04)00097-7 [DOI] [PubMed] [Google Scholar]
  236. Rainero I., Degennaro T., Visentin G., Brunetti E., Cerrato P., Torre E., et al. (1990). Effects of chronic ethanol treatment on Alpha-Msh concentrations in rat-brain and pituitary. Neuropeptides 15 139–141. 10.1016/0143-4179(90)90145-O [DOI] [PubMed] [Google Scholar]
  237. Rajora N., Boccoli G., Burns D., Sharma S., Catania A. P., Lipton J. M. (1997). alpha-MSH modulates local and circulating tumor necrosis factor-alpha in experimental brain inflammation. J. Neurosci. 17 2181–2186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  238. Ransohoff R. M., El Khoury J. (2015). Microglia in health and disease. Cold Spring Harb. Perspect. Biol. 8:a020560 10.1101/cshperspect.a020560 [DOI] [PMC free article] [PubMed] [Google Scholar]
  239. Retamal M. A., Cortes C. J., Reuss L., Bennett M. V., Saez J. C. (2006). S-nitrosylation and permeation through connexin 43 hemichannels in astrocytes: induction by oxidant stress and reversal by reducing agents. Proc. Natl. Acad. Sci. U.S.A. 103 4475–4480. 10.1073/pnas.0511118103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  240. Retamal M. A., Froger N., Palacios-Prado N., Ezan P., Saez P. J., Saez J. C., et al. (2007). Cx43 hemichannels and gap junction channels in astrocytes are regulated oppositely by proinflammatory cytokines released from activated microglia. J. Neurosci. 27 13781–13792. 10.1523/JNEUROSCI.2042-07.2007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  241. Riikonen J., Jaatinen P., Rintala J., Porsti I., Karjala K., Hervonen A. (2002). Intermittent ethanol exposure increases the number of cerebellar microglia. Alcohol Alcohol. 37 421–426. 10.1093/alcalc/37.5.421 [DOI] [PubMed] [Google Scholar]
  242. Rolls E. T. (2015). Limbic systems for emotion and for memory, but no single limbic system. Cortex 62 119–157. 10.1016/j.cortex.2013.12.005 [DOI] [PubMed] [Google Scholar]
  243. Ron D., Barak S. (2016). Molecular mechanisms underlying alcohol-drinking behaviours. Nat. Rev. Neurosci. 17 576–591. 10.1038/nrn.2016.85 [DOI] [PMC free article] [PubMed] [Google Scholar]
  244. Rose A. J., Richter E. A. (2005). Skeletal muscle glucose uptake during exercise: how is it regulated? Physiology (Bethesda) 20 260–270. [DOI] [PubMed] [Google Scholar]
  245. Roselli-Rehfuss L., Mountjoy K. G., Robbins L. S., Mortrud M. T., Low M. J., Tatro J. B., et al. (1993). Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc. Natl. Acad. Sci. U.S.A. 90 8856–8860. 10.1073/pnas.90.19.8856 [DOI] [PMC free article] [PubMed] [Google Scholar]
  246. Russo A., Palumbo M., Scifo C., Cardile V., Barcellona M. L., Renis M. (2001). Ethanol-induced oxidative stress in rat astrocytes: role of HSP70. Cell Biol. Toxicol. 17 153–168. 10.1023/A:1011936313510 [DOI] [PubMed] [Google Scholar]
  247. Sáez P. J., Shoji K. F., Retamal M. A., Harcha P. A., Ramirez G., Jiang J. X., et al. (2013). ATP is required and advances cytokine-induced gap junction formation in microglia In Vitro. Mediators Inflamm. 2013 16 10.1155/2013/216402 [DOI] [PMC free article] [PubMed] [Google Scholar]
  248. Saito M., Chakraborty G., Hui M., Masiello K. (2016). Ethanol-induced neurodegeneration and glial activation in the developing brain. Brain Sci. 6:E31 10.3390/brainsci6030031 [DOI] [PMC free article] [PubMed] [Google Scholar]
  249. Saito M., Chakraborty G., Mao R. F., Paik S. M., Vadasz C. (2010). Tau phosphorylation and cleavage in ethanol-induced neurodegeneration in the developing mouse brain. Neurochem. Res. 35 651–659. 10.1007/s11064-009-0116-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  250. Sakamoto K., Hirshman M. F., Aschenbach W. G., Goodyear L. J. (2002). Contraction regulation of Akt in rat skeletal muscle. J. Biol. Chem. 277 11910–11917. 10.1074/jbc.M112410200 [DOI] [PubMed] [Google Scholar]
  251. Salameh A., Blanke K., Dhein S. (2013). Mind the gap! Connexins and pannexins in physiology, pharmacology and disease. Front. Pharmacol. 4:144 10.3389/fphar.2013.00144 [DOI] [PMC free article] [PubMed] [Google Scholar]
  252. Salazar M., Pariente J. A., Salido G. M., Gonzalez A. (2008). Ethanol induces glutamate secretion by Ca2+ mobilization and ROS generation in rat hippocampal astrocytes. Neurochem. Int. 52 1061–1067. 10.1016/j.neuint.2007.11.001 [DOI] [PubMed] [Google Scholar]
  253. Santofimia-Castaño P., Salido G. M., Gonzalez A. (2011). Ethanol reduces kainate-evoked glutamate secretion in rat hippocampal astrocytes. Brain Res. 1402 1–8. 10.1016/j.brainres.2011.05.059 [DOI] [PubMed] [Google Scholar]
  254. Sari Y., Toalston J. E., Rao P. S., Bell R. L. (2016). Effects of ceftriaxone on ethanol, nicotine or sucrose intake by alcohol-preferring (P) rats and its association with GLT-1 expression. Neuroscience 326 117–125. 10.1016/j.neuroscience.2016.04.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  255. Schafer D. P., Lehrman E. K., Stevens B. (2013). The “quad-partite” synapse: microglia-synapse interactions in the developing and mature CNS. Glia 61 24–36. 10.1002/glia.22389 [DOI] [PMC free article] [PubMed] [Google Scholar]
  256. Schaible E. V., Steinstrasser A., Jahn-Eimermacher A., Luh C., Sebastiani A., Kornes F., et al. (2013). Single administration of tripeptide alpha-MSH(11-13) attenuates brain damage by reduced inflammation and apoptosis after experimental traumatic brain injury in mice. PLoS ONE 8:e71056 10.1371/journal.pone.0071056 [DOI] [PMC free article] [PubMed] [Google Scholar]
  257. Schipke C. G., Boucsein C., Ohlemeyer C., Kirchhoff F., Kettenmann H. (2002). Astrocyte Ca2+ waves trigger responses in microglial cells in brain slices. FASEB J. 16 255–257. [DOI] [PubMed] [Google Scholar]
  258. Schneider E. R., Rada P., Darby R. D., Leibowitz S. F., Hoebel B. G. (2007). Orexigenic peptides and alcohol intake: differential effects of orexin, galanin, and ghrelin. Alcohol. Clin. Exp. Res. 31 1858–1865. 10.1111/j.1530-0277.2007.00510.x [DOI] [PubMed] [Google Scholar]
  259. Seeley R. J., Woods S. C. (2003). Monitoring of stored and available fuel by the CNS: implications for obesity. Nat. Rev. Neurosci. 4 901–909. 10.1038/nrn1245 [DOI] [PubMed] [Google Scholar]
  260. Selkirk J. V., Nottebaum L. M., Lee J., Yang W., Foster A. C., Lechner S. M. (2007). Identification of differential melanocortin 4 receptor agonist profiles at natively expressed receptors in rat cortical astrocytes and recombinantly expressed receptors in human embryonic kidney cells. Neuropharmacology 52 459–466. 10.1016/j.neuropharm.2006.08.015 [DOI] [PubMed] [Google Scholar]
  261. Shaikh S. B., Uy B., Perera A., Nicholson L. F. B. (2012). AGEs-RAGE mediated up-regulation of connexin43 in activated human microglial CHME-5 cells. Neurochem. Int. 60 640–651. 10.1016/j.neuint.2012.02.023 [DOI] [PubMed] [Google Scholar]
  262. Shen Y., Fu W. Y., Cheng E. Y., Fu A. K., Ip N. Y. (2013). Melanocortin-4 receptor regulates hippocampal synaptic plasticity through a protein kinase A-dependent mechanism. J. Neurosci. 33 464–472. 10.1523/JNEUROSCI.3282-12.2013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  263. Silverman W. R., De Rivero Vaccari J. P., Locovei S., Qiu F., Carlsson S. K., Scemes E., et al. (2009). The pannexin 1 channel activates the inflammasome in neurons and astrocytes. J. Biol. Chem. 284 18143–18151. 10.1074/jbc.M109.004804 [DOI] [PMC free article] [PubMed] [Google Scholar]
  264. Simard M., Arcuino G., Takano T., Liu Q. S., Nedergaard M. (2003). Signaling at the gliovascular interface. J. Neurosci. 23 9254–9262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  265. Slawecki C. J., Thorsell A., Ehlers C. L. (2004). Long-term neurobehavioral effects of alcohol or nicotine exposure in adolescent animal models. Ann. N. Y. Acad. Sci. 1021 448–452. 10.1196/annals.1308.062 [DOI] [PubMed] [Google Scholar]
  266. Smith K. L., John C. S., Sypek E. I., Ongur D., Cohen B. M., Barry S. M., et al. (2014). Exploring the role of central astrocytic glutamate uptake in ethanol reward in mice. Alcohol. Clin. Exp. Res. 38 1307–1314. 10.1111/acer.12361 [DOI] [PubMed] [Google Scholar]
  267. Smith T. L., Zsigo A. (1996). Increased Na+-dependent high affinity uptake of glutamate in astrocytes chronically exposed to ethanol. Neurosci. Lett. 218 142–144. 10.1016/S0304-3940(96)13123-2 [DOI] [PubMed] [Google Scholar]
  268. Sosinsky G. E., Boassa D., Dermietzel R., Duffy H. S., Laird D. W., Macvicar B. A., et al. (2011). Pannexin channels are not gap junction hemichannels. Channels 5 193–197. 10.4161/chan.5.3.15765 [DOI] [PMC free article] [PubMed] [Google Scholar]
  269. Spaccapelo L., Bitto A., Galantucci M., Ottani A., Irrera N., Minutoli L., et al. (2011). Melanocortin MC4 receptor agonists counteract late inflammatory and apoptotic responses and improve neuronal functionality after cerebral ischemia. Eur. J. Pharmacol. 670 479–486. 10.1016/j.ejphar.2011.09.015 [DOI] [PubMed] [Google Scholar]
  270. Spanagel R. (2009). Alcoholism: a systems approach from molecular physiology to addictive behavior. Physiol. Rev. 89 649–705. 10.1152/physrev.00013.2008 [DOI] [PubMed] [Google Scholar]
  271. Spear L. P., Swartzwelder H. S. (2014). Adolescent alcohol exposure and persistence of adolescent-typical phenotypes into adulthood: a mini-review. Neurosci. Biobehav. Rev. 45 1–8. 10.1016/j.neubiorev.2014.04.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  272. Ste Marie L., Luquet S., Cole T. B., Palmiter R. D. (2005). Modulation of neuropeptide Y expression in adult mice does not affect feeding. Proc. Natl. Acad. Sci. U.S.A. 102 18632–18637. 10.1073/pnas.0509240102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  273. Steinberg L. (2007). Risk taking in adolescence - New perspectives from brain and behavioral science. Curr. Dir. Psychol. Sci. 16 55–59. 10.1111/j.1467-8721.2007.00475.x [DOI] [Google Scholar]
  274. Steiner J. L., Crowell K. T., Lang C. H. (2015). Impact of alcohol on glycemic control and insulin action. Biomolecules 5 2223–2246. 10.3390/biom5042223 [DOI] [PMC free article] [PubMed] [Google Scholar]
  275. Streit W. J. (2001). Microglia and macrophages in the developing CNS. Neurotoxicology 22 619–624. 10.1016/S0161-813X(01)00033-X [DOI] [PubMed] [Google Scholar]
  276. Stridh M. H., Tranberg M., Weber S. G., Blomstrand F., Sandberg M. (2008). Stimulated efflux of amino acids and glutathione from cultured hippocampal slices by omission of extracellular calcium: likely involvement of connexin hemichannels. J. Biol. Chem. 283 10347–10356. 10.1074/jbc.M704153200 [DOI] [PMC free article] [PubMed] [Google Scholar]
  277. Suk K. (2007). Microglial signal transduction as a target of alcohol action in the brain. Curr. Neurovasc. Res. 4 131–142. 10.2174/156720207780637261 [DOI] [PubMed] [Google Scholar]
  278. Takeuchi H., Jin S., Wang J., Zhang G., Kawanokuchi J., Kuno R., et al. (2006). Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J. Biol. Chem. 281 21362–21368. 10.1074/jbc.M600504200 [DOI] [PubMed] [Google Scholar]
  279. Tau G. Z., Peterson B. S. (2010). Normal development of brain circuits. Neuropsychopharmacology 35 147–168. 10.1038/npp.2009.115 [DOI] [PMC free article] [PubMed] [Google Scholar]
  280. Thorsell A., Slawecki C. J., Ehlers C. L. (2005). Effects of neuropeptide Y and corticotropin-releasing factor on ethanol intake in Wistar rats: interaction with chronic ethanol exposure. Behav. Brain Res. 161 133–140. 10.1016/j.bbr.2005.01.016 [DOI] [PubMed] [Google Scholar]
  281. Traynelis S. F., Wollmuth L. P., Mcbain C. J., Menniti F. S., Vance K. M., Ogden K. K., et al. (2010). Glutamate receptor ion channels: structure, regulation, and function. Pharmacol. Rev. 62 405–496. 10.1124/pr.109.002451 [DOI] [PMC free article] [PubMed] [Google Scholar]
  282. Truitt J. M., Blednov Y. A., Benavidez J. M., Black M., Ponomareva O., Law J., et al. (2016). Inhibition of IKKβ reduces ethanol consumption in C57BL/6J mice. eNeuro 3 10.1523/ENEURO.0256-16.2016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  283. Tsai G., Coyle J. T. (1998). The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu. Rev. Med. 49 173–184. 10.1146/annurev.med.49.1.173 [DOI] [PubMed] [Google Scholar]
  284. Udomuksorn W., Mukem S., Kumarnsit E., Vongvatcharanon S., Vongvatcharanon U. (2011). Effects of alcohol administration during adulthood on parvalbumin and glial fibrillary acidic protein immunoreactivity in the rat cerebral cortex. Acta Histochem. 113 283–289. 10.1016/j.acthis.2009.11.001 [DOI] [PubMed] [Google Scholar]
  285. Umhau J. C., Momenan R., Schwandt M. L., Singley E., Lifshitz M., Doty L., et al. (2010). Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study. Arch. Gen. Psychiatry 67 1069–1077. 10.1001/archgenpsychiatry.2010.125 [DOI] [PMC free article] [PubMed] [Google Scholar]
  286. Upadhya S. C., Tirumalai P. S., Boyd M. R., Mori T., Ravindranath V. (2000). Cytochrome P4502E (CYP2E) in brain: constitutive expression, induction by ethanol and localization by fluorescence in situ hybridization. Arch. Biochem. Biophys. 373 23–34. 10.1006/abbi.1999.1477 [DOI] [PubMed] [Google Scholar]
  287. Vaisse C., Clement K., Durand E., Hercberg S., Guy-Grand B., Froguel P. (2000). Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J. Clin. Invest. 106 253–262. 10.1172/JCI9238 [DOI] [PMC free article] [PubMed] [Google Scholar]
  288. Vaisse C., Clement K., Guy-Grand B., Froguel P. (1998). A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat. Genet. 20 113–114. 10.1038/2407 [DOI] [PubMed] [Google Scholar]
  289. Valles S. L., Blanco A. M., Pascual M., Guerri C. (2004). Chronic ethanol treatment enhances inflammatory mediators and cell death in the brain and in astrocytes. Brain Pathol. 14 365–371. 10.1111/j.1750-3639.2004.tb00079.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  290. Varela L., Horvath T. L. (2012). Leptin and insulin pathways in POMC and AgRP neurons that modulate energy balance and glucose homeostasis. EMBO Rep. 13 1079–1086. 10.1038/embor.2012.174 [DOI] [PMC free article] [PubMed] [Google Scholar]
  291. Vargova L., Sykova E. (2014). Astrocytes and extracellular matrix in extrasynaptic volume transmission. Philos. Trans. R. Soc. Lond. B Biol. Sci. 369 20130608 10.1098/rstb.2013.0608 [DOI] [PMC free article] [PubMed] [Google Scholar]
  292. Verderio C., Matteoli M. (2001). ATP mediates calcium signaling between astrocytes and microglial cells: modulation by IFN-gamma. J. Immunol. 166 6383–6391. 10.4049/jimmunol.166.10.6383 [DOI] [PubMed] [Google Scholar]
  293. Volterra A., Meldolesi J. (2005). Astrocytes, from brain glue to communication elements: the revolution continues. Nat. Rev. Neurosci. 6 626–640. 10.1038/nrn1722 [DOI] [PubMed] [Google Scholar]
  294. Voss-Andreae A., Murphy J. G., Ellacott K. L., Stuart R. C., Nillni E. A., Cone R. D., et al. (2007). Role of the central melanocortin circuitry in adaptive thermogenesis of brown adipose tissue. Endocrinology 148 1550–1560. 10.1210/en.2006-1389 [DOI] [PubMed] [Google Scholar]
  295. Walrave L., Vinken M., Albertini G., De Bundel D., Leybaert L., Smolders I. J. (2016). Inhibition of connexin43 hemichannels impairs spatial short-term memory without affecting spatial working memory. Front. Cell Neurosci. 10:288 10.3389/fncel.2016.00288 [DOI] [PMC free article] [PubMed] [Google Scholar]
  296. Wang X., Chu G., Yang Z., Sun Y., Zhou H., Li M., et al. (2015). Ethanol directly induced HMGB1 release through NOX2/NLRP1 inflammasome in neuronal cells. Toxicology 334 104–110. 10.1016/j.tox.2015.06.006 [DOI] [PubMed] [Google Scholar]
  297. Wasserman D. H. (2009). Four grams of glucose. Am. J. Physiol. Endocrinol. Metab. 296 E11–E21. 10.1152/ajpendo.90563.2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  298. Watts L. T., Rathinam M. L., Schenker S., Henderson G. I. (2005). Astrocytes protect neurons from ethanol-induced oxidative stress and apoptotic death. J. Neurosci. Res. 80 655–666. 10.1002/jnr.20502 [DOI] [PubMed] [Google Scholar]
  299. Weidenfeld J., Crumeyrolle-Arias M., Haour F. (1995). Effect of bacterial endotoxin and interleukin-1 on prostaglandin biosynthesis by the hippocampus of mouse brain: role of interleukin-1 receptors and glucocorticoids. Neuroendocrinology 62 39–46. 10.1159/000126986 [DOI] [PubMed] [Google Scholar]
  300. Weilinger N. L., Lohman A. W., Rakai B. D., Ma E. M., Bialecki J., Maslieieva V., et al. (2016). Metabotropic NMDA receptor signaling couples Src family kinases to pannexin-1 during excitotoxicity. Nat. Neurosci. 19 432–442. 10.1038/nn.4236 [DOI] [PubMed] [Google Scholar]
  301. White A. M., Matthews D. B., Best P. J. (2000). Ethanol, memory, and hippocampal function: a review of recent findings. Hippocampus 10 88–93. [DOI] [PubMed] [Google Scholar]
  302. World Health Organization (2014). Global Status Report on Alcohol and Health. Geneva: World Health Organization Press. [Google Scholar]
  303. Wilkes J. J., Nagy L. E. (1996). Chronic ethanol feeding impairs glucose tolerance but does not produce skeletal muscle insulin resistance in rat epitrochlearis muscle. Alcohol. Clin. Exp. Res. 20 1016–1022. 10.1111/j.1530-0277.1996.tb01940.x [DOI] [PubMed] [Google Scholar]
  304. Williams K. W., Scott M. M., Elmquist J. K. (2011). Modulation of the central melanocortin system by leptin, insulin, and serotonin: co-ordinated actions in a dispersed neuronal network. Eur. J. Pharmacol. 660 2–12. 10.1016/j.ejphar.2010.11.042 [DOI] [PMC free article] [PubMed] [Google Scholar]
  305. Woodward J. J. (2000). Ethanol and NMDA receptor signaling. Crit. Rev. Neurobiol. 14 69–89. 10.1615/CritRevNeurobiol.v14.i1.40 [DOI] [PubMed] [Google Scholar]
  306. Wu J., Lee M. R., Choi S., Kim T., Choi D. S. (2010). ENT1 regulates ethanol-sensitive EAAT2 expression and function in astrocytes. Alcohol. Clin. Exp. Res. 34 1110–1117. 10.1111/j.1530-0277.2010.01187.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  307. Wu J., Lee M. R., Kim T., Johng S., Rohrback S., Kang N., et al. (2011). Regulation of ethanol-sensitive EAAT2 expression through adenosine A1 receptor in astrocytes. Biochem. Biophys. Res. Commun. 406 47–52. 10.1016/j.bbrc.2011.01.104 [DOI] [PMC free article] [PubMed] [Google Scholar]
  308. Wuchert F., Ott D., Rafalzik S., Roth J., Gerstberger R. (2009). Tumor necrosis factor-alpha, interleukin-1beta and nitric oxide induce calcium transients in distinct populations of cells cultured from the rat area postrema. J. Neuroimmunol. 206 44–51. 10.1016/j.jneuroim.2008.10.010 [DOI] [PubMed] [Google Scholar]
  309. Xu A. W., Barsh G. S. (2006). MC4R neurons weigh in differently. Nat. Neurosci. 9 15–16. 10.1038/nn0106-15 [DOI] [PubMed] [Google Scholar]
  310. Yakovleva T., Bazov I., Watanabe H., Hauser K. F., Bakalkin G. (2011). Transcriptional control of maladaptive and protective responses in alcoholics: a role of the NF-kappaB system. Brain Behav. Immun. 25(Suppl. 1) S29–S38. 10.1016/j.bbi.2010.12.019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  311. Yamazoe M., Shiosaka S., Yagura A., Kawai Y., Shibasaki T., Ling N., et al. (1984). The distribution of alpha-melanocyte stimulating hormone (alpha-MSH) in the central nervous system of the rat: an immunohistochemical study. II. Lower brain stem. Peptides 5 721–727. 10.1016/0196-9781(84)90013-5 [DOI] [PubMed] [Google Scholar]
  312. Yang J. Y., Xue X., Tian H., Wang X. X., Dong Y. X., Wang F., et al. (2014). Role of microglia in ethanol-induced neurodegenerative disease: pathological and behavioral dysfunction at different developmental stages. Pharmacol. Ther. 144 321–337. 10.1016/j.pharmthera.2014.07.002 [DOI] [PubMed] [Google Scholar]
  313. Yeo G. S., Farooqi I. S., Aminian S., Halsall D. J., Stanhope R. G., O’rahilly S. (1998). A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat. Genet. 20 111–112. 10.1038/2404 [DOI] [PubMed] [Google Scholar]
  314. Yeo G. S., Lank E. J., Farooqi I. S., Keogh J., Challis B. G., O’rahilly S. (2003). Mutations in the human melanocortin-4 receptor gene associated with severe familial obesity disrupts receptor function through multiple molecular mechanisms. Hum. Mol. Genet. 12 561–574. 10.1093/hmg/ddg057 [DOI] [PubMed] [Google Scholar]
  315. Yi C., Mei X., Ezan P., Mato S., Matias I., Giaume C., et al. (2016). Astroglial connexin43 contributes to neuronal suffering in a mouse model of Alzheimer’s disease. Cell Death. Differ. 23 1691–1701. 10.1038/cdd.2016.63 [DOI] [PMC free article] [PubMed] [Google Scholar]
  316. Yki-Jarvinen H., Nikkila E. A. (1985). Ethanol decreases glucose utilization in healthy man. J. Clin. Endocrinol. Metab. 61 941–945. 10.1210/jcem-61-5-941 [DOI] [PubMed] [Google Scholar]
  317. Yu B., Schroeder A., Nagy L. E. (2000). Ethanol stimulates glucose uptake and translocation of GLUT-4 in H9c2 myotubes via a Ca(2+)-dependent mechanism. Am. J. Physiol. Endocrinol. Metab. 279 E1358–E1365. [DOI] [PubMed] [Google Scholar]
  318. Zeigler D. W., Wang C. C., Yoast R. A., Dickinson B. D., Mccaffree M. A., Robinowitz C. B., et al. (2005). The neurocognitive effects of alcohol on adolescents and college students. Prev. Med. 40 23–32. 10.1016/j.ypmed.2004.04.044 [DOI] [PubMed] [Google Scholar]
  319. Zhang Y., Bo Q., Wu W., Xu C., Yu G., Ma S., et al. (2015). alpha-Melanocyte-stimulating hormone prevents glutamate excitotoxicity in developing chicken retina via MC4R-mediated down-regulation of microRNA-194. Sci. Rep. 5:15812 10.1038/srep15812 [DOI] [PMC free article] [PubMed] [Google Scholar]
  320. Zhao Y. N., Wang F., Fan Y. X., Ping G. F., Yang J. Y., Wu C. F. (2013). Activated microglia are implicated in cognitive deficits, neuronal death, and successful recovery following intermittent ethanol exposure. Behav. Brain Res. 236 270–282. 10.1016/j.bbr.2012.08.052 [DOI] [PubMed] [Google Scholar]
  321. Zink M., Schmitt A., Vengeliene V., Henn F. A., Spanagel R. (2004). Ethanol induces expression of the glutamate transporters EAAT1 and EAAT2 in organotypic cortical slice cultures. Alcohol. Clin. Exp. Res. 28 1752–1757. 10.1097/01.ALC.0000145810.12545.B3 [DOI] [PubMed] [Google Scholar]
  322. Zohar M., Salomon Y. (1992). Melanocortins stimulate proliferation and induce morphological-changes in cultured rat astrocytes by distinct transducing mechanisms. Brain Res. 576 49–58. 10.1016/0006-8993(92)90608-C [DOI] [PubMed] [Google Scholar]

Articles from Frontiers in Cellular Neuroscience are provided here courtesy of Frontiers Media SA

RESOURCES